tag:blogger.com,1999:blog-45236735947412186452024-03-13T12:27:48.878-07:00Kamdhenu HealthSEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.comBlogger18125tag:blogger.com,1999:blog-4523673594741218645.post-22221337768938941222017-12-15T06:32:00.002-08:002017-12-15T06:32:44.437-08:00Plz DONATE<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="post-body entry-content" id="post-body-929610835623853419" itemprop="description articleBody" style="background-color: white; font-family: arial, tahoma, helvetica, freesans, sans-serif; line-height: 16.3636px; position: relative; width: 586.167px;">
<div dir="ltr" trbidi="on">
<div class="entry-content" style="line-height: 26px;">
<div style="color: #333333; font-size: 16px; text-align: center;">
<strong><span style="color: #666666;">KAMDHENU(Regd.Trust)</span></strong></div>
<div style="color: #333333; font-size: 16px;">
<div style="text-align: center;">
<strong><span style="color: #666666;">Registered in section 12(A) No.CIT-1/T/120(K-41)Agra/2004-05/3261</span></strong></div>
</div>
<div style="color: #333333; font-size: 16px;">
<div style="text-align: center;">
<strong><span style="color: #666666; font-size: xx-small;"><em>Donations for this trust are eligible for tax relief U/S-80G of income tax act 1961</em></span></strong></div>
<div style="text-align: center;">
<strong><span style="color: #666666; font-size: xx-small;"><em><br /></em></span></strong></div>
<div style="text-align: center;">
<b style="text-align: left;">KAMDHENUDHAM, PATNAGARH</b></div>
</div>
<div style="color: #333333;">
<span style="font-size: 16px; text-align: justify;">Our organization (kamdhenu) is a national </span><span style="font-size: 16px; text-align: justify;">organization</span><span style="font-size: 16px; text-align: justify;">. we try to develop the poor-villages in Odisha by training the farmers on cow based cultivation and cottage industry with preserving forest, water, soil and wild life. In Odisha more than 200 villages have already been undertaken and village committees have been formed. For this purpose 7 acres of land has been taken (2.5 acres from donation) 13 Kilometers away from Patnagarh city.</span></div>
<div style="color: #333333; font-size: 16px; text-align: justify;">
<br /></div>
<div style="color: #333333; font-size: 16px;">
<strong>What we humbly need from you:-</strong></div>
<div style="color: #333333;">
1- Cow shed: 60’x20’ tin thatched shed. Costing about =Rs. 3,60,000/-</div>
<div style="color: #333333;">
2- Office: 20’x15’ R C C roof Costing about= Rs.150,000/-</div>
<div style="color: #333333;">
3- Medicine manufacturing shed: 10’x40’ hall Costing about =Rs. 2,00,000/-</div>
<div style="color: #333333;">
4- Compost(manure) making pit(10.no.s) 6’x12’x6’ pit@=Rs 5000/- each =Rs.50,000/-</div>
<div style="color: #333333;">
5- Shelter for old age & disable Cattle (100 nos.) 40 sq. ft/cow , total 4000 sq ft @Rs. 30/ sq. ft = Rs. 1,20,000/-</div>
<div style="color: #333333;">
6- Feed go-down (dried fodder store)= Rs. 50,000/-</div>
<div style="color: #333333;">
7- Free health centre: 15’x20’ costing about Rs:1,80,000/-</div>
<div style="color: #333333;">
8- Residential quarter: 4-no.s x 1,00,000/- =Rs. 4,00,000/-</div>
<div style="color: #333333;">
9- Borewell ,motor and over head tank with all fittings Rs. 1,20,000/-</div>
<div style="color: #333333;">
<br /></div>
<div style="color: #333333;">
<b style="font-size: 16px;">Objectives of KAMDHENUDHAM, PATNAGARH</b></div>
<div style="color: #333333;">
1- Farmer training about cow based cultivation.</div>
<div style="color: #333333;">
2- Ayurvedic (panchgavya) medicine.</div>
<div style="color: #333333;">
3- Bio-organic product.</div>
<div style="color: #333333;">
4- Self employment scheme for rural people.</div>
<div style="color: #333333;">
5- Free health service.</div>
<div style="color: #333333;">
6- Cottage industry.</div>
<div style="color: #333333;">
7- Preservation and improvement of live stock.</div>
<div style="color: #333333;">
8- Herbal garden.</div>
<div style="color: #333333;">
<br /></div>
<div style="color: #333333;">
For details plz visit: www.sevika.org/, www.kamdhenudham.blogspot.com/</div>
<div style="color: #333333;">
Email:info@sevika.org, kamdhenudham@gmail.com/ymail.com</div>
<div style="color: #333333;">
Mobile: +91 9938712663</div>
<div style="color: #333333;">
<br /></div>
<div style="color: #333333;">
<br /></div>
<div style="color: #333333;">
<span style="font-size: 16px; text-decoration-line: underline;"><strong><span style="color: red; font-size: small;">Donation for </span></strong><span style="color: red; font-size: small;"><strong>Old Age Home</strong></span></span></div>
<div style="color: #333333;">
<span class="Apple-style-span" style="color: red; font-size: 16px;"><br /></span></div>
<div style="color: #333333;">
<span class="Apple-style-span" style="color: red; font-size: 16px;"><br /></span></div>
<table border="1" style="color: #333333; font-size: 14px; margin: 0px 0px 20px; width: 800px;"><tbody>
<tr><td bgcolor="#800080" colspan="3" style="padding: 6px 24px;"><div align="center">
<strong><span class="Apple-style-span" style="color: red;">Donation for Old Age Home</span></strong></div>
</td></tr>
<tr><td align="center" bgcolor="#008080" colspan="2" style="padding: 6px 24px;" width="194"><strong><span class="Apple-style-span" style="color: red;">Amount</span></strong></td><td align="center" bgcolor="#008080" style="padding: 6px 24px;" width="599"><strong><span class="Apple-style-span" style="color: red;">Details</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span class="Apple-style-span" style="color: red;">INR</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span class="Apple-style-span" style="color: red;">USD</span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">1000</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">20</span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"><strong><span style="color: red; font-size: xx-small;">Medicines Boxes </span></strong></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">2000</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">40</span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"><strong><span style="color: red; font-size: xx-small;">1 Meal / Bed Side Lockers / Bed Sheets</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">3000</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">60</span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"><strong><span class="Apple-style-span" style="color: red;"><span style="font-size: xx-small;">Almirah</span><span style="font-size: xx-small;"> / Cup Board</span></span></strong></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">5000</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">100</span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"><strong><span style="color: red; font-size: xx-small;">SEMI (Fowler) / Tilt Bed / A Days food</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">10,000</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">200</span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"><strong><span style="color: red; font-size: xx-small;">Television / Air Cooler</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">15,000</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">300 </span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"><strong><span style="color: red; font-size: xx-small;">Water Cooler/ Kitchen Equipment / Kitchen Crockery</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">20,000</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">400</span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"><strong><span style="color: red; font-size: xx-small;">To look after an aged person per year</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">25,000</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">500</span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"><strong><span style="color: red; font-size: xx-small;">Dining Hall Furniture</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">50,000</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">1000</span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"><strong><span style="color: red; font-size: xx-small;">Dormitory Construction/Laundry Equipment / Freezer Box</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">1 Lakh</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">2000</span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"><strong><span style="color: red; font-size: xx-small;">Single Room in memory of your beloved ones./fixed deposit towards corpus fund.</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">1.5 Lakhs</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">3000</span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"><strong><span style="color: red; font-size: xx-small;">Double Room</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">2 Lakhs</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">4000</span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"><strong><span style="color: red; font-size: xx-small;">Medical Equipment / Physiotherapy Equipment</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">2.5 Lakhs</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">5000</span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"><strong><span style="color: red; font-size: xx-small;">Ambulance</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">3 Lakhs</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">6000</span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"><strong><span style="color: red; font-size: xx-small;">Sharing Room Unit</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCCC00" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">5 Lakhs</span></strong></td><td align="center" bgcolor="#99FFCC" style="padding: 6px 24px;" width="97"><strong><span style="color: red; font-size: xx-small;">10,000</span></strong></td><td bgcolor="#FFCCFF" style="padding: 6px 24px;" width="599"><strong><span style="color: red; font-size: xx-small;">Construction Dormitory (20 Beds)</span></strong></td></tr>
</tbody></table>
<div style="color: #333333;">
<span style="font-size: 16px; text-decoration-line: underline;"><strong><span style="color: red; font-size: small;"><a href="http://www.blogger.com/post-edit.g?blogID=6262335878972962962&postID=929610835623853419" name="cowshelter" style="color: #015782; text-decoration-line: none;"></a></span></strong></span><br /></div>
<div style="color: #333333;">
<span style="font-size: 16px; text-decoration-line: underline;"><strong><span style="color: red; font-size: small;">Donation for </span></strong><span style="color: red; font-size: small;"><strong>Cow Shelter</strong></span></span></div>
<div style="color: #333333;">
<span class="Apple-style-span" style="color: red; font-size: 16px;"><br /></span></div>
<div style="color: #333333;">
<em style="font-size: 16px;"><span style="color: red; font-size: xx-small;"><strong>We are planning to construct “Shri KAMDHENU GAU SEVA KENDRA” with adequate facilities for Medical Treatment and housing for 100 cows.</strong></span></em></div>
<div style="color: #333333;">
<span class="Apple-style-span" style="color: red; font-size: 16px;"><br /></span></div>
<table border="1" style="color: #333333; font-size: 14px; margin: 0px 0px 20px; width: 700px;"><tbody>
<tr><td bgcolor="#800000" colspan="2" style="padding: 6px 24px;"><div align="center">
<strong><span class="Apple-style-span" style="color: red;">Requirement for “Shri kamdhenu Gau Seva Kendra”</span></strong></div>
</td></tr>
<tr><td align="center" bgcolor="#808000" style="padding: 6px 24px;" width="165"><strong><span class="Apple-style-span" style="color: red;">Amount</span></strong></td><td align="center" bgcolor="#808000" style="padding: 6px 24px;" width="628"><strong><span class="Apple-style-span" style="color: red;">Details</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCFF33" style="padding: 6px 24px;" width="165"><span style="color: red; font-size: xx-small;">Rs.2,51,000</span></td><td bgcolor="#CCFF99" style="padding: 6px 24px;" width="628"><span style="color: red; font-size: xx-small;">Compound wall with Gate</span></td></tr>
<tr><td align="center" bgcolor="#CCFF33" style="padding: 6px 24px;" width="165"><span style="color: red; font-size: xx-small;">Rs.3,51,000</span></td><td bgcolor="#CCFF99" style="padding: 6px 24px;" width="628"><span style="color: red; font-size: xx-small;">Cow Shed Construction</span></td></tr>
<tr><td align="center" bgcolor="#CCFF33" style="padding: 6px 24px;" width="165"><span style="color: red; font-size: xx-small;">Rs.50,000</span></td><td bgcolor="#CCFF99" style="padding: 6px 24px;" width="628"><span style="color: red; font-size: xx-small;">Ceiling Fans for Shed 50 nos. at Rs. 1000 each</span></td></tr>
<tr><td align="center" bgcolor="#CCFF33" style="padding: 6px 24px;" width="165"><span style="color: red; font-size: xx-small;">Rs.1,51,000</span></td><td bgcolor="#CCFF99" style="padding: 6px 24px;" width="628"><span style="color: red; font-size: xx-small;">Water supply facilities with Tube-Well</span></td></tr>
<tr><td align="center" bgcolor="#CCFF33" style="padding: 6px 24px;" width="165"><span style="color: red; font-size: xx-small;">Rs.2,50,000</span></td><td bgcolor="#CCFF99" style="padding: 6px 24px;" width="628"><span style="color: red; font-size: xx-small;">Grass Godown</span></td></tr>
</tbody></table>
<table border="1" style="color: #333333; font-size: 14px; margin: 0px 0px 20px; width: 700px;"><tbody>
<tr><td bgcolor="#800000" colspan="2" style="padding: 6px 24px;"><div align="center">
<strong><span class="Apple-style-span" style="color: red;">Special Scheme for “Shri Kamdhenu Gau Seva Kendra”</span></strong></div>
</td></tr>
<tr><td align="center" bgcolor="#808000" style="padding: 6px 24px;" width="165"><strong><span class="Apple-style-span" style="color: red;">Amount</span></strong></td><td align="center" bgcolor="#808000" style="padding: 6px 24px;" width="628"><strong><span class="Apple-style-span" style="color: red;">Details</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCFF33" style="padding: 6px 24px;" width="165"><span style="color: red; font-size: xx-small;">Rs.5000</span></td><td bgcolor="#CCFF99" style="padding: 6px 24px;" width="628"><span style="color: red; font-size: xx-small;">Operation and Medical expense for 1 cow</span></td></tr>
<tr><td align="center" bgcolor="#CCFF33" style="padding: 6px 24px;" width="165"><span style="color: red; font-size: xx-small;">Rs.3501</span></td><td bgcolor="#CCFF99" style="padding: 6px 24px;" width="628"><span style="color: red; font-size: xx-small;">One day Fodder expense for 25 cows</span></td></tr>
<tr><td align="center" bgcolor="#CCFF33" style="padding: 6px 24px;" width="165"><span style="color: red; font-size: xx-small;">Rs.11,001</span></td><td bgcolor="#CCFF99" style="padding: 6px 24px;" width="628"><span style="color: red; font-size: xx-small;">Kansar Seva for cows On Birthday / Gokulashthami/Ekadasi/Paryushan</span></td></tr>
<tr><td align="center" bgcolor="#CCFF33" style="padding: 6px 24px;" width="165"><span style="color: red; font-size: xx-small;">Rs.2000</span></td><td bgcolor="#CCFF99" style="padding: 6px 24px;" width="628"><span style="color: red; font-size: xx-small;">Ambulance expenses for one cow one time</span></td></tr>
</tbody></table>
<table border="1" style="color: #333333; font-size: 14px; margin: 0px 0px 20px; width: 700px;"><tbody>
<tr><td bgcolor="#800000" colspan="2" style="padding: 6px 24px;"><div align="center">
<strong><span class="Apple-style-span" style="color: red;">Life Membership for “Shri Kamdhenu Gau Seva Kendra” (From interest income)</span></strong></div>
</td></tr>
<tr><td align="center" bgcolor="#808000" style="padding: 6px 24px;" width="165"><strong><span class="Apple-style-span" style="color: red;">Amount</span></strong></td><td align="center" bgcolor="#808000" style="padding: 6px 24px;" width="628"><strong><span class="Apple-style-span" style="color: red;">Details</span></strong></td></tr>
<tr><td align="center" bgcolor="#CCFF33" style="padding: 6px 24px;" width="165"><span class="Apple-style-span" style="color: red;"><span style="font-size: xx-small;">Rs.1,51,00</span><span style="font-size: xx-small;">1</span></span></td><td bgcolor="#CCFF99" style="padding: 6px 24px;" width="628"><span style="color: red; font-size: xx-small;">Seva for 31 cows for 12 months</span></td></tr>
<tr><td align="center" bgcolor="#CCFF33" style="padding: 6px 24px;" width="165"><span style="color: red; font-size: xx-small;">Rs.75,001</span></td><td bgcolor="#CCFF99" style="padding: 6px 24px;" width="628"><span style="color: red; font-size: xx-small;">Seva for 31 cows for 6 months</span></td></tr>
<tr><td align="center" bgcolor="#CCFF33" style="padding: 6px 24px;" width="165"><span style="color: red; font-size: xx-small;">Rs.40,001</span></td><td bgcolor="#CCFF99" style="padding: 6px 24px;" width="628"><span style="color: red; font-size: xx-small;">Seva for 31 cows for 3months</span></td></tr>
<tr><td align="center" bgcolor="#CCFF33" style="padding: 6px 24px;" width="165"><span style="color: red; font-size: xx-small;">Rs.10,000</span></td><td bgcolor="#CCFF99" style="padding: 6px 24px;" width="628"><span style="color: red; font-size: xx-small;">Seva for 31 cows for 1 months</span></td></tr>
</tbody></table>
</div>
</div>
<div style="clear: both; color: #333333; font-size: 12.7273px;">
</div>
</div>
<div class="post-footer" style="background-color: white; color: #333333; font-family: arial, tahoma, helvetica, freesans, sans-serif; font-size: 12.7273px; line-height: 1.6; margin: 1.5em 0px 0px;">
<div class="post-footer-line post-footer-line-1">
<span class="post-author vcard" style="margin-left: 0px; margin-right: 1em;"><br /></span></div>
<div class="post-footer-line post-footer-line-1">
<span class="post-author vcard" style="margin-left: 0px; margin-right: 1em;">Posted by <span class="fn" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><a href="http://www.blogger.com/profile/09757876524180224516" rel="author" style="color: #015782; text-decoration-line: none;" title="author profile"><span itemprop="name">KAMDHENUDHAM</span> </a></span></span><span class="post-timestamp" style="margin-left: -1em; margin-right: 1em;">at <a class="timestamp-link" href="http://kamdhenudham.blogspot.in/2011/08/donate.html" rel="bookmark" style="color: #015782; text-decoration-line: none;" title="permanent link"><abbr class="published" itemprop="datePublished" style="border: none;" title="2011-08-21T00:32:00-07:00">8/21/2011</abbr></a> </span><span class="post-comment-link" style="margin-right: 1em;"><a class="comment-link" href="http://www.blogger.com/comment.g?blogID=6262335878972962962&postID=929610835623853419" style="color: #015782; text-decoration-line: none; white-space: nowrap;">No comments: </a></span><span class="post-icons" style="margin-right: 1em;"><span class="item-action"><a href="http://www.blogger.com/email-post.g?blogID=6262335878972962962&postID=929610835623853419" style="color: #015782; text-decoration-line: none;" title="Email Post"><img alt="" class="icon-action" height="13" src="https://img1.blogblog.com/img/icon18_email.gif" style="border: none !important; margin: 0px 0px 0px 0.5em !important; position: relative; vertical-align: middle;" width="18" /> </a></span><span class="item-control blog-admin pid-1242229322" style="display: inline;"><a href="http://www.blogger.com/post-edit.g?blogID=6262335878972962962&postID=929610835623853419&from=pencil" style="color: #015782; text-decoration-line: none;" title="Edit Post"><img alt="" class="icon-action" height="18" src="https://img2.blogblog.com/img/icon18_edit_allbkg.gif" style="border: none !important; margin: 0px 0px 0px 0.5em !important; position: relative; vertical-align: middle;" width="18" /></a></span></span></div>
</div>
</div>
SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-38242654068003433332017-12-15T05:54:00.002-08:002017-12-15T06:21:03.320-08:00<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="text-align: justify;">
<span style="color: #38761d; font-family: "arial" , "sans-serif"; font-size: 18pt;">Interests:</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: cyan; font-family: "arial" , "sans-serif"; font-size: 18pt;"> </span><span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Service to the Cow & mankind, research and developments, Health, Environment, Agriculture, Horticultur, Plantetion etc…….</span></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: #38761d; font-family: "arial" , "sans-serif"; font-size: 18pt;">Vision:</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;"> We will create aditee's own Bio-organic world. </span></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: green; font-family: "arial" , "sans-serif"; font-size: 18pt;">About me</span><span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">:</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;"> Every day, about 30 consultatio attend and accordingly give the respective Ayurvedic Diagnosis and Panchagavya (cow's medicinal products) Treatments. Here each and everyone may step in and receive the healing blessing of Go Mata, The Mother of Mankind, Goddess of Gods and the Worshiped Deity of Parameshvar, Shri Govinda.</span></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: olive; font-family: "arial" , "sans-serif"; font-size: 18pt;">I feel...: </span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;"> (</span><span style="color: #339966; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu Gosthhi</span><span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">) is creating a protective layer for resistance of future unexpected exposures. How can we protect ourselves and universe???? Assure profoundly study our safety programs.</span><br />
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Following promise I take to myself:</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">1- Every day I’ll protect at least a tree.</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">2- Every week I'll plant a new tree.</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">3- I’ll do havan (YAGNYA ) and pray to sun for genuine nature & avoid sun ’s warmness.</span></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: lime; font-family: "arial" , "sans-serif"; font-size: 18pt;">Our medicines</span><span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">:</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu makoya ark</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu yogendra rash</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu trayodasang google</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu rasonadi google</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu medohar google</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu abhaa google</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu kachnar google</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu keisor google</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu asmarinasak churn</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu abipatikar churn</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu Ubtan</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu soap</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu iye drops</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu malham</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu mazik tail</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Kamdhenu chyavanprass</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">Etc….</span></div>
<br />
<div class="MsoNormal" style="text-align: justify;">
</div>
<br />
<div class="MsoNormal" style="-webkit-text-stroke-width: 0px; color: black; font-family: "Times New Roman"; font-size: medium; font-style: normal; font-variant-caps: normal; font-variant-ligatures: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-decoration-color: initial; text-decoration-style: initial; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;">
<div style="margin: 0px;">
<br />
<ol>
<li><span style="color: green; font-family: "arial" , "sans-serif"; font-size: 18pt;">Donations</span><span style="color: blue; font-family: "arial" , "sans-serif"; font-size: 18pt;">: Donations to kamdhenu dham vrindaban are tax exempt in India under Section 80 G of the Income Tax Act.1961.</span></li>
</ol>
</div>
</div>
</div>
SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-72495731807103731792015-03-27T00:55:00.003-07:002015-03-27T00:55:59.108-07:00kidney problem<div dir="ltr" style="text-align: left;" trbidi="on">
<img alt="Displaying 20150304_095413.jpg" src="https://mail.google.com/mail/u/0/?ui=2&ik=9543debecf&view=fimg&th=14c26a9f0ae5a3b3&attid=0.1&disp=inline&realattid=35e6168e019fb4dd_0.1&safe=1&attbid=ANGjdJ81kg8qDDKGAJ4d92m8XSN-THBnsQFcFRyGjkmAQLtroXEqt9XZovgr2jWgDAGNZp1WqMaz8c8_bh6OyBrD6MmvQyXs3jF4XuxZ6zlLO94v9VtDE8MrFI9WGNo&ats=1427442808106&rm=14c26a9f0ae5a3b3&zw&sz=w1336-h547" /> this report is only 15 days taken panchagavya medicines after reduce critine 3,7 to 2.2</div>
SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-60060669025340346332014-07-27T00:53:00.002-07:002014-07-27T00:53:31.785-07:00Maha panchagavya ghreet<div dir="ltr" style="text-align: left;" trbidi="on">
<h1 class="entry-title" style="color: #333333; font-family: Oswald, arial, serif; font-size: 30px; font-weight: normal; line-height: 1.25; margin: 0px 0px 10px; padding: 0px;">
Maha Panchagavya Ghrita – Benefits, Dosage, How To Use, Side Effects, Ingredients, Reference</h1>
<div class="entry-content" style="color: #333333; font-family: Lora, serif; font-size: 16px; line-height: 25px; overflow: hidden;">
<div style="line-height: 1.5625; margin-bottom: 25px; padding: 0px;">
Maha Panchagavya Ghrita is an Ayurvedic medicine, in herbal ghee form.This medicine has ghee as its base. It is used for preparatory procedure for Panchakarma and also as medicine.<span id="more-148"></span><strong></strong></div>
<div style="line-height: 1.5625; margin-bottom: 25px; padding: 0px;">
<strong>Please note</strong> that it is different from Panchagavya ghrita<br /><strong>Maha Panchagavya Ghrita benefits: </strong><br />It is used as medicine and also in preparatory procedure called snehakarma for the treatment of fever, epilepsy, fistula, inflammation, piles, liver diseases, anemia, cough and psychiatric conditions.</div>
<div style="line-height: 1.5625; margin-bottom: 25px; padding: 0px;">
<strong>Synonyms: </strong>Maha Panchagavya ghritam, Maha Panchagavy Ghrit<br /><strong>Effect on Tridosha - </strong>Calms Vata, Pitta and Kapha.<br /><strong><br /></strong><strong>Maha Panchagavya Ghrita dosage: </strong><br />As medicine – quarter to half teaspoon with water, usually before food, once or twice a day, or as directed by Ayurvedic doctor.<br />For Panchakarma preparation – Snehana procedure, the dose depends on the disease status and the judgement of Ayurvedic doctor.<br /><strong></strong></div>
<div style="line-height: 1.5625; margin-bottom: 25px; padding: 0px;">
<strong>Maha Panchagavya Ghrita Side Effects: </strong><br />There are no known side effects with this medicine. However it is best to use this product under medical supervision. Self medication with this medicine is discouraged.<br />People with diabetes, high cholesterol, heart diseases and high BP should excise precaution.<br />In very high dose, it may cause diarrhoea and indigestion.</div>
<div style="float: right; margin: 10px 0px 10px 10px;">
<ins style="border: none; display: inline-table; height: 250px; margin: 0px; padding: 0px; position: relative; visibility: visible; width: 300px;"><ins id="aswift_0_anchor" style="border: none; display: block; height: 250px; margin: 0px; padding: 0px; position: relative; visibility: visible; width: 300px;"><iframe allowfullscreen="true" allowtransparency="true" frameborder="0" height="250" hspace="0" id="aswift_0" marginheight="0" marginwidth="0" name="aswift_0" scrolling="no" style="left: 0px; position: absolute; top: 0px;" vspace="0" width="300"></iframe></ins></ins></div>
<div style="line-height: 1.5625; margin-bottom: 25px; padding: 0px;">
<strong>Maha Panchagavya Ghrita Ingredients: </strong><br />96 grams of each of<br />Dashamoola group of roots -<br />Bilva – Aegle marmelos<br />Agnimantha – Premna mucronata<br />Shyonaka – Oroxylum indicum<br />Gambhari – Gmelina arborea<br />Patala – Stereospermum suaveolens<br />Shalaparni – Desmodium gangeticum<br />Prinshnaparni – Urarica picta<br />Gokshura – Tribulus terrestris<br />Brihati – Solanum indicum<br />Kantakari – Solanum xanthocarpum,<br />Triphala – Haritaki (Terminalia chebula), Vibhitaki (Terminalia bellirica) Amla (Emblica officinalis)<br />Haridra – Turmeric<br />Daruharidra – Berberis aristata<br />Kutaja – Holarrhena antidysenterica<br />Saptaparna – Alstonia scholaris<br />Apamarga – Achyranthes aspera<br />Nilini - Indigofera tinctoria<br />Katurohini – Picrorhiza kurroa<br />Shampaka – Cassia fistula<br />Pushkaramoola – Inula racemosa<br />Phalgumoola – Ficus carica<br />Duralabha – Alhagi psudalhagi<br />water for decoction – 12.288 liters, boiled and reduced to 3.072 liters<br />powders of 12 grams of each of<br />Bharngi – Clerodendron serratum<br />Patha – Cissampelos pariera<br />Adhaki – Cajanus cajan<br />Kumbha – Operculina turpethum<br />Nikumbha – Baliospermum montanum<br />Trikatu – pepper, long pepper and ginger<br />Rohisha – Cymbopogon martinii<br />Murva - Marsdenia tenacissima<br />Bhutika - Trachyspermum ammi<br />Bhunimba – Andrographis paniculata<br />Shreyasi – Piper chaba<br />Sariva – Hemidesmus indicus<br />Madayantika – Lawsonia inermis<br />Agni – Plumbago zeylanica<br />Nichula - Barringtonia acutangula<br />Gomaya swarasa – the water extract prepared from cow dung – 768 ml<br />ksheera – cow milk - 768 ml<br />Dadhi – cow cheese - 768 ml<br />Mutra – Cow urine - 768 ml<br />Ghritham – ghee – 768 grams<br />The above combination is heated till herbal ghee is prepared.</div>
</div>
</div>
SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-53353824954473893762014-07-27T00:50:00.000-07:002014-07-27T00:50:09.943-07:00PANCHAGAVYA<div dir="ltr" style="text-align: left;" trbidi="on">
<h1 class="entry-title" style="color: #333333; font-family: Oswald, arial, serif; font-size: 30px; font-weight: normal; line-height: 1.25; margin: 0px 0px 10px; padding: 0px;">
Benefits, Dosage, How To Use, Side Effects, Ingredients, Reference</h1>
<div class="entry-content" style="color: #333333; font-family: Lora, serif; font-size: 16px; line-height: 25px; overflow: hidden;">
<div style="line-height: 1.5625; margin-bottom: 25px; padding: 0px;">
Panchagavya Ghrita is an Ayurvedic medicine, in herbal ghee form.This medicine has ghee as its base. It is used for preparatory procedure for Panchakarma and also as medicine. Panchagavyam refers to five different components of cow products.<span id="more-137"></span></div>
<div style="line-height: 1.5625; margin-bottom: 25px; padding: 0px;">
<strong>Panchagavya Ghrita benefits: </strong><br />
It is widely used as medicine and also in preparatory procedure called snehakarma for the treatment of<br />
neurological and psychiatric conditions, fever, liver diseases such as jaundice.</div>
<div style="line-height: 1.5625; margin-bottom: 25px; padding: 0px;">
<strong>Effect on Tridosha - </strong>Calms Pitta and kapha<br />
<strong></strong><br />
<strong>Panchagavya Ghrita</strong><strong> dosage: </strong><br />
As medicine – quarter to half teaspoon with water, usually before food, once or twice a day, or as directed by Ayurvedic doctor.<br />
For Panchakarma preparation – Snehana procedure, the dose depends on the disease status and the judgement of Ayurvedic doctor.<br />
<strong></strong><br />
It is usually administered with warm water.<strong>Ghrita</strong><strong> Side Effects: </strong></div>
There are no known side effects with this medicine. However it is best to use this product under medical supervision. Self medication with this medicine is discouraged.<br />
People with diabetes, high cholesterol, heart diseases and high BP should excise precaution.<br />
In very high dose, it may cause diarrhoea and indigestion.<br />
<strong></strong><br />
<strong>Panchagavya Ghrita</strong><strong> Ingredients: </strong><br />
Gomaya swarasa – the water extract prepared from cow dung – 3.072 liters<br />
ksheera – cow milk – 3.072 liters<br />
Dadhi – cow cheese – 3.072 kg<br />
Mutra – Cow urine – 3.072 liters<br />
Ghritham – ghee – 768 grams<br />
The above combination is heated till herbal ghee is prepared.</div>
<div class="entry-content" style="color: #333333; font-family: Lora, serif; font-size: 16px; line-height: 25px; overflow: hidden;">
<strong>Ghrita</strong><strong> Side Effects: </strong><br />
There are no known side effects with this medicine. However it is best to use this product under medical supervision. Self medication with this medicine is discouraged.<br />
People with diabetes, high cholesterol, heart diseases and high BP should excise precaution.<br />
In very high dose, it may cause diarrhoea and indigestion.<br />
<strong></strong><br />
<strong>Panchagavya Ghrita</strong><strong> Ingredients: </strong><br />
Gomaya swarasa – the water extract prepared from cow dung – 3.072 liters<br />
ksheera – cow milk – 3.072 liters<br />
Dadhi – cow cheese – 3.072 kg<br />
Mutra – Cow urine – 3.072 liters<br />
Ghritham – ghee – 768 grams<br />
The above combination is heated till herbal ghee is prepared.</div>
<div class="entry-content" style="color: #333333; font-family: Lora, serif; font-size: 16px; line-height: 25px; overflow: hidden;">
<strong>Ghrita</strong><strong> Side Effects: </strong><br />
There are no known side effects with this medicine. However it is best to use this product under medical supervision. Self medication with this medicine is discouraged.<br />
People with diabetes, high cholesterol, heart diseases and high BP should excise precaution.<br />
In very high dose, it may cause diarrhoea and indigestion.<br />
<strong></strong><br />
<strong>Panchagavya Ghrita</strong><strong> Ingredients: </strong><br />
Gomaya swarasa – the water extract prepared from cow dung – 3.072 liters<br />
ksheera – cow milk – 3.072 liters<br />
Dadhi – cow cheese – 3.072 kg<br />
Mutra – Cow urine – 3.072 liters<br />
Ghritham – ghee – 768 grams<br />
The above combination is heated till herbal ghee is prepared.</div>
</div>
SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-79880245625555055432012-05-28T20:12:00.001-07:002012-05-28T20:12:23.453-07:00A mega project planned for tribal uplift, pilgrim amenity centre<a href="http://www.thehindu.com/news/cities/Kochi/article3349123.ece">The Hindu : Cities / Kochi : A mega project planned for tribal uplift, pilgrim amenity centre</a>SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-15545447298071884432011-11-06T06:19:00.000-08:002011-11-06T06:19:40.656-08:00Effects of Kamdhenu Ark<div dir="ltr" style="text-align: left;" trbidi="on"><br />
<div class="MsoNormal"></div><div class="MsoNormal">Effects of Kamdhenu Ark and Active Immunization by Gonadotropin</div><div class="MsoNormal">Releasing Hormone Conjugate (GnRH-BSA) on Gonadosomatic<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">Indices (GSI) and Sperm Parameters in Male Mus musculus</div><div class="MsoNormal">Javid Ahmad Ganaie, Varsha Gautam, Vinoy Kumar Shrivastava</div><div class="MsoNormal">* </div><div class="MsoNormal">- Endocrinology Laboratory, Department of Biosciences, Barkatullah University, Bhopal, India </div><div class="MsoNormal">Abstract</div><div class="MsoNormal">Background: Active immunization against GnRH decreases the secretion of gonadotropins and causes cessation of gonadal function, thereby, inducing infertility. Based </div><div class="MsoNormal">on the immunoenhancing activity of Kamdhenu ark (distilled cow urine), this study </div><div class="MsoNormal">was performed to evaluate its effects on the gonadosomatic indices (GSI) and sperm </div><div class="MsoNormal">parameters in male mice receiving a GnRH contraceptive vaccine.<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">Methods: Sixty adult male mice of Parke’s strain were divided into three groups of </div><div class="MsoNormal">twenty. Group I served as the controls, while group II was immunized by GnRH-BSA </div><div class="MsoNormal">conjugate (50/0.2/35 µg/ml/g BW) by four intraperitoneal injections at different intervals on days 1, 30, 60 and 90. However, group III was supplemented daily by oral </div><div class="MsoNormal">Kamdhenu ark (100<span style="mso-spacerun: yes;"> </span>ppm) along with GnRH-BSA immunizations. The animals were </div><div class="MsoNormal">sacrificed after 30, 60, 90 and 120 days and their testis and epididymis were dissected </div><div class="MsoNormal">out weighed and semen analysis was performed.<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">Results: GSI values, sperm motility, sperm count and sperm morphology in male Mus </div><div class="MsoNormal">musculus were decreased significantly in all the experimental groups as compared to </div><div class="MsoNormal">the control group (p<0.01). Kamdhenu ark significantly enhanced the effect of GnRH </div><div class="MsoNormal">vaccine on the aforesaid parameters especially in 90 and 120 days treated groups </div><div class="MsoNormal">(p<0.05). </div><div class="MsoNormal">Conclusion: The changes witnessed in sperm parameters suggested that the GnRHBSA immunization suppressed the activities of gonadotropins and testosterone directly through hypothalamo-hypophysial-gonadal<span style="mso-spacerun: yes;"> </span>axis and indirectly by acting on the </div><div class="MsoNormal">testes which may modulate the sperm morphology, sperm count and motility. However, Kamdhenu ark seems to have enhanced these effects because of its immunemodulatory properties too. </div><div class="MsoNormal">Keywords:<span style="mso-spacerun: yes;"> </span>GnRH-BSA, Gonadosomatic indices (GSI), Immunization, Kamdhenu ark,<span style="mso-spacerun: yes;"> </span>Mus </div><div class="MsoNormal">musculus, Sperm parameters. </div><div class="MsoNormal">To cite this article: Ganaie JA, Gautam V, Shrivastava<span style="mso-spacerun: yes;"> </span>VK. Effects of Kamdhenu Ark and Active </div><div class="MsoNormal">Immunization by Gonadotropin Releasing Hormone Conjugate (GnRH-BSA) on Gonadosomatic Indices </div><div class="MsoNormal">(GSI) and Sperm Parameters in Male Mus musculus. J Reprod Infertil. 2011;12(1):3-7.</div><div class="MsoNormal">Background</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>onadotropin-releasing hormone (GnRH) con-<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>trols the production of gonadotropins, thereby having an orchestrating effect on the reproductive hormone cascade and spermatogenesis (1). </div><div class="MsoNormal">Active immunization against GnRH has successfully suppressed the secretion of gonadotropins </div><div class="MsoNormal">and decreased sperm production, follicular development, ovulation and conception in male and female mammals (2, 3). Vaccination against GnRH </div><div class="MsoNormal">blocks the hypothalamic-pituitary- gonadal axis.<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">Therefore, it can be used as an alternative for </div><div class="MsoNormal">castration and fertility control in farm animals, </div><div class="MsoNormal">companion animals and wildlife species (4-6). </div><div class="MsoNormal">Application of GnRH vaccination in humans has </div><div class="MsoNormal">been suggested for controlling fertility-related </div><div class="MsoNormal">endocrine disorders and gonadal steroid-dependent diseases (7). Active immunization of adult </div><div class="MsoNormal">animals against GnRH causes the loss of synthesis </div><div class="MsoNormal">and secretion of gonadotropins and cessation of </div><div class="MsoNormal">gonadal function as long as the antibody titers </div><div class="MsoNormal">* Corresponding Author:<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">Vinoy Kumar Shrivastava, </div><div class="MsoNormal">Endocrinology </div><div class="MsoNormal">Laboratory, Department<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">of Bioscience, Barkatullah </div><div class="MsoNormal">University, Bhopal (M.P.) </div><div class="MsoNormal">India. </div><div class="MsoNormal">E-mail:<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">vinoyks2001@yahoo.com</div><div class="MsoNormal">Received: May 9, 2010 </div><div class="MsoNormal">Accepted: Aug. 10, 2010<span style="mso-spacerun: yes;"> </span>J Reprod Infertil, Vol 12, No 1, Jan/ Mar 2011 </div><div class="MsoNormal">JRI Kamdhenu ark and GnRH-BSA immunization </div><div class="MsoNormal">4 </div><div class="MsoNormal">remain elevated (8). </div><div class="MsoNormal">It has been reported that cow urine contains all </div><div class="MsoNormal">beneficial elements such as chemical properties, </div><div class="MsoNormal">potentialities and constituents that are capable of </div><div class="MsoNormal">removing all the ill effects and imbalances of </div><div class="MsoNormal">body caused by various infectious agents and </div><div class="MsoNormal">toxicants. In this way, it ensures a protection </div><div class="MsoNormal">against various ailments including the most </div><div class="MsoNormal">dreaded diseases like cancer, diabetes, hepatitis </div><div class="MsoNormal">etc. (9). Kamdhenu ark (distilled cow urine) has </div><div class="MsoNormal">been reported as a strong immunomodulator and </div><div class="MsoNormal">bioenhancer by various researchers (10, 11). </div><div class="MsoNormal">Experimental studies of Rangasamy and Kaliappan revealed the protective effects of cow urine on </div><div class="MsoNormal">haematological, serum biochemical parameters </div><div class="MsoNormal">and immune status of broilers (12).<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">The present study attempts to evaluate the </div><div class="MsoNormal">effects of GnRH-BSA immunization on gonadosomatic indices (GSI) and sperm parameters in </div><div class="MsoNormal">male mice and to examine the modulatory role of </div><div class="MsoNormal">Kamdhenu ark following the immunization.</div><div class="MsoNormal">Methods</div><div class="MsoNormal">Sixty adult male mice, Mus musculus, of Parke’s </div><div class="MsoNormal">strain (P), weighing 30±5<span style="mso-spacerun: yes;"> </span>g were used in the </div><div class="MsoNormal">study. The animals were divided into three groups </div><div class="MsoNormal">of twenty. The mice in Group I served as the </div><div class="MsoNormal">controls, receiving intraperitoneal Phosphate </div><div class="MsoNormal">Buffered Saline (PBS) injections (100<span style="mso-spacerun: yes;"> </span>µl) on the </div><div class="MsoNormal">1</div><div class="MsoNormal">st</div><div class="MsoNormal">, 30</div><div class="MsoNormal">th</div><div class="MsoNormal">, 60</div><div class="MsoNormal">th</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>and 90</div><div class="MsoNormal">th</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>days, while the mice in </div><div class="MsoNormal">group II were immunized by GnRH-BSA conjugate (50/0.2/35<span style="mso-spacerun: yes;"> </span>µg/ml/g BW) (Sigma-Aldrich, </div><div class="MsoNormal">USA) dissolved in 100 µl of phosphate buffered </div><div class="MsoNormal">solution (0.01 N) emulsified with an equal volume </div><div class="MsoNormal">(100<span style="mso-spacerun: yes;"> </span>µl) of Freund’s adjuvant (Sigma Aldrich, </div><div class="MsoNormal">USA). GnRH-BSA injections were given intraperitoneally at different intervals, i.e. on days 1</div><div class="MsoNormal">st</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>,</div><div class="MsoNormal">30</div><div class="MsoNormal">th</div><div class="MsoNormal">, 60</div><div class="MsoNormal">th</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>and 90</div><div class="MsoNormal">th</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>However, the mice in group III .</div><div class="MsoNormal">were supplemented with daily Kamdhenu ark </div><div class="MsoNormal">(100<span style="mso-spacerun: yes;"> </span>ppm) (Gaytri Shakti Peeth, India) orally </div><div class="MsoNormal">along with the intraperitoneal injections of GnRHBSA. Five animals from each group were </div><div class="MsoNormal">sacrificed in monthly intervals, i.e. on days 30, 60, </div><div class="MsoNormal">90 and 120 and their testes and epididymides were </div><div class="MsoNormal">quickly dissected. The testes were weighed for </div><div class="MsoNormal">observing gonadosomatic indices [gonad weight/ </div><div class="MsoNormal">100<span style="mso-spacerun: yes;"> </span>g BW], while the epididymides were processed for semen analysis,<span style="mso-spacerun: yes;"> </span>i.e. sperm motility, </div><div class="MsoNormal">sperm count and morphology by Prasad method </div><div class="MsoNormal">(13). Cauda epididymides were dissected out to </div><div class="MsoNormal">release sperms in normal saline (100<span style="mso-spacerun: yes;"> </span>mg tissue/<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">2<span style="mso-spacerun: yes;"> </span>ml N.S.) for sperm suspension.<span style="mso-spacerun: yes;"> </span>For studying </div><div class="MsoNormal">sperm morphology, Leishman`s stain was used </div><div class="MsoNormal">and the slides were finally observed at 400× </div><div class="MsoNormal">magnification (14). </div><div class="MsoNormal">Statistical Analysis: The collected data were analyzed through one way ANOVA and post-hoc </div><div class="MsoNormal">methods using EZANOVA software. P-values </div><div class="MsoNormal"><0.05 or <0.01 were considered significant while </div><div class="MsoNormal">values <0.001 were considered as highly significant.</div><div class="MsoNormal">Results</div><div class="MsoNormal">GSI values decreased in all the experimental </div><div class="MsoNormal">groups compared to the control group. However, </div><div class="MsoNormal">more significant decrease in GSI was observed in </div><div class="MsoNormal">the group treated by Kamdhenu ark along with </div><div class="MsoNormal">GnRH-BSA, especially in the later part of the </div><div class="MsoNormal">experiment (p<0.01) (Table 1). Moreover, sperm </div><div class="MsoNormal">motility and sperm count significantly decreased </div><div class="MsoNormal">throughout the investigation in all the treated </div><div class="MsoNormal">groups compared to the control group (p<0.01)</div><div class="MsoNormal">(Table 2). However, some mice immunized by </div><div class="MsoNormal">GnRH-BSA + Kamdhenu ark also showed decreased values for sperm motility and count than </div><div class="MsoNormal">the GnRH-BSA immunized groups (p<0.05). The </div><div class="MsoNormal">Table 1. Gonadosomatic indices (GSI) in the experimental and control groups of </div><div class="MsoNormal">male mice, Mus musculus,after different intervals </div><div class="MsoNormal">Group </div><div class="MsoNormal">GSI (gonad weight/100 g BW) </div><div class="MsoNormal">Duration </div><div class="MsoNormal">30 days 60 days 90 days 120 days </div><div class="MsoNormal">Control<span style="mso-spacerun: yes;"> </span>0.40 ± 0.02<span style="mso-spacerun: yes;"> </span>0.43 ± 0.05<span style="mso-spacerun: yes;"> </span>0.50 ± 0.01<span style="mso-spacerun: yes;"> </span>0.54 ± 0.04 </div><div class="MsoNormal">GnRH-BSA<span style="mso-spacerun: yes;"> </span>0.36 ± 0.06 0.30<span style="mso-spacerun: yes;"> </span>± 0.02 </div><div class="MsoNormal">a</div><div class="MsoNormal">* 0.23 ± 0.00 </div><div class="MsoNormal">a</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>0.16 ± 0.00 </div><div class="MsoNormal">a</div><div class="MsoNormal">GnRH-BSA + KA<span style="mso-spacerun: yes;"> </span>0.32±0.03<span style="mso-spacerun: yes;"> </span>0.26± 0.01 </div><div class="MsoNormal">a</div><div class="MsoNormal">0.19±0.01 </div><div class="MsoNormal">ab</div><div class="MsoNormal">0.12±0.00 </div><div class="MsoNormal">ab</div><div class="MsoNormal">Mean ± SEM of five animals (Accuracy of calculation up to two decimal digits) </div><div class="MsoNormal">a</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>= Significant difference with the controls in the same column (p< 0.01)<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">b</div><div class="MsoNormal">= Significant difference with GnRH-BSA groups in the same column (p< 0.01) </div><div class="MsoNormal">* = Significant differences (p< 0.05)<span style="mso-spacerun: yes;"> </span><span style="mso-spacerun: yes;"> </span>J Reprod Infertil, Vol 12, No 1, Jan/ Mar 2011 </div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>Ganaie JA, et al.<span style="mso-spacerun: yes;"> </span>JRI</div><div class="MsoNormal">5</div><div class="MsoNormal">percentage of morphologically normal sperm decreased significantly with increased percentage of </div><div class="MsoNormal">abnormal forms of sperms, i.e. pin head, large </div><div class="MsoNormal">head, oval head, double head, head less, bent </div><div class="MsoNormal">neck, looping mid piece, coiled-tail, double-tailed, </div><div class="MsoNormal">tailless in all the experimental groups as compared </div><div class="MsoNormal">to the control group (p<0.01) (Table 3, Figure 1). </div><div class="MsoNormal">Moreover, some significant alterations in normal </div><div class="MsoNormal">sperm morphology, such as large head, headless </div><div class="MsoNormal">and pin head sperm were also observed in GnRHBSA + Kamdhenu ark treated group when compared with GnRH-BSA, especially in the later part </div><div class="MsoNormal">of the experiment (p<0.01). </div><div class="MsoNormal">Discussion</div><div class="MsoNormal">The endocrine effects of active immunization </div><div class="MsoNormal">against GnRH have been studied in a variety of </div><div class="MsoNormal">young adult male and female animals (15-17). </div><div class="MsoNormal">Experimental studies have demonstrated decreases in gonadotropins, sperm production, </div><div class="MsoNormal">follicular development, ovulation and conception </div><div class="MsoNormal">after immunization against GnRH, chemically </div><div class="MsoNormal">conjugated to a carrier protein. GnRH immuneization affected sperm motility and sperm counts </div><div class="MsoNormal">in ram lambs, boars and colts (18, 19). Several </div><div class="MsoNormal">other experimental studies have revealed the </div><div class="MsoNormal">deleterious effects of immunization against GnRH </div><div class="MsoNormal">on different sperm parameters in rats, bulls, </div><div class="MsoNormal">stallions, cats and dogs (20-24).</div><div class="MsoNormal">Cow urine has been tested for its immunomodulatory properties that enhance both cellular </div><div class="MsoNormal">and humoral immune responses (25, 26). Kamdhenu ark (distilled cow urine) has been reported to </div><div class="MsoNormal">increase the humoral immunity in rats (27).<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">Chauhan<span style="mso-spacerun: yes;"> </span>et al., (2004) observed that Kamdhenu </div><div class="MsoNormal">ark may modulate the immune responses because </div><div class="MsoNormal">it increases the secretion of interleukin-1 and 2 </div><div class="MsoNormal">Table 2. Sperm motility and sperm count in the experimental and control groups of male mice, Mus musculus, after </div><div class="MsoNormal">different intervals </div><div class="MsoNormal">Parameters Group </div><div class="MsoNormal">Duration</div><div class="MsoNormal">30 days 60 days 90 days 120 days </div><div class="MsoNormal">Sperm Motility (%) </div><div class="MsoNormal">Control<span style="mso-spacerun: yes;"> </span>59.00±4.33<span style="mso-spacerun: yes;"> </span>63.76±2.77<span style="mso-spacerun: yes;"> </span>65.05±2.31<span style="mso-spacerun: yes;"> </span>69.60±3.19 </div><div class="MsoNormal">GnRH-BSA<span style="mso-spacerun: yes;"> </span>39.40±3.81</div><div class="MsoNormal">a</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>21.56±1.36</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>a</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>13.00±2.11</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>a</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>9.40±1.14</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>a</div><div class="MsoNormal">GnRH-BSA+ KA<span style="mso-spacerun: yes;"> </span>33.80±1.72</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>a</div><div class="MsoNormal">17.06±1.00</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>ab</div><div class="MsoNormal">* 10.46±1.65</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>a</div><div class="MsoNormal">7.16±0.95</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>a</div><div class="MsoNormal">Sperm Count (million/ml) </div><div class="MsoNormal">Control<span style="mso-spacerun: yes;"> </span>62.00±3.18 68.60±2.10<span style="mso-spacerun: yes;"> </span>75.50±3.76 78.00±2.11 </div><div class="MsoNormal">GnRH-BSA<span style="mso-spacerun: yes;"> </span>49.10±2.65</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>a</div><div class="MsoNormal">35.22±3.21</div><div class="MsoNormal">a</div><div class="MsoNormal">21.00±2.20 </div><div class="MsoNormal">a</div><div class="MsoNormal">16.42±1.78 </div><div class="MsoNormal">a</div><div class="MsoNormal">GnRH-BSA + KA<span style="mso-spacerun: yes;"> </span>44.18±2.82 </div><div class="MsoNormal">a</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>26.12±2.00</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>ab</div><div class="MsoNormal">* 18.30±1.90 </div><div class="MsoNormal">a</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>12.34±1.10 </div><div class="MsoNormal">ab</div><div class="MsoNormal">*</div><div class="MsoNormal">Mean ± SEM of five animals (Accuracy of calculation up to two decimal digits) </div><div class="MsoNormal">a</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>= Significant difference with the controls in the same column (p< 0.01)<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">b</div><div class="MsoNormal">= Significant difference with the GnRH-BSA groups in the same column (p< 0.01) </div><div class="MsoNormal">* = Significant differences (p< 0.05)</div><div class="MsoNormal">Figure 1. Normal morphological sperm forms in the controls </div><div class="MsoNormal">(A) and morphologically abnormal sperms after GnRH-BSA </div><div class="MsoNormal">and Kamdhenu ark along with GnRH-BSA administration (BI) in male Mus musculus.<span style="mso-spacerun: yes;"> </span>J Reprod Infertil, Vol 12, No 1, Jan/ Mar 2011 </div><div class="MsoNormal">JRI Kamdhenu ark and GnRH-BSA immunization </div><div class="MsoNormal">6 </div><div class="MsoNormal">(28). Recently, Ganaie and Shrivastava reported </div><div class="MsoNormal">the modulatory effects of Kamdhenu ark on </div><div class="MsoNormal">GnRH-BSA immunization in female mice (29).<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">In corroboration to above studies, our study also </div><div class="MsoNormal">revealed that GnRH-BSA immunization significantly decreased the values of GSI, sperm motility, count and morphology in male Mus musculus. </div><div class="MsoNormal">The aforesaid parameters diminished more significantly in the group supplemented with Kamdhenu </div><div class="MsoNormal">ark along with GnRH-BSA immunization. All </div><div class="MsoNormal">these changes in GSI and sperm parameters </div><div class="MsoNormal">suggested that GnRH-BSA immunization could </div><div class="MsoNormal">have directly suppressed the activities of gonadotropins and testosterone through hypothalamohypophysial-gonadal axis or might have indirectly </div><div class="MsoNormal">affected the testicular tissue. However, more </div><div class="MsoNormal">significant decreases in the parameters after </div><div class="MsoNormal">Kamdhenu ark supplementation may be because </div><div class="MsoNormal">of its modulatory and bioenhancing properties.</div><div class="MsoNormal">Acknowledgement</div><div class="MsoNormal">The authors gratefully acknowledge the help and </div><div class="MsoNormal">financial support of Professor Meenakshi Benerjee, the head of Department of Biosciences, </div><div class="MsoNormal">Barkatullah University, Bhopal (M.P), India.</div><div class="MsoNormal">References </div><div class="MsoNormal">1. Garner LL, Campbell GT, Blake CA. Luteinizing </div><div class="MsoNormal">hormone (LH)-releasing hormone: chronic effects </div><div class="MsoNormal">on LH and follicle-stimulating hormone cells and </div><div class="MsoNormal">secretion in adult male rats. Endocrinology. 1990; </div><div class="MsoNormal">126(2):992-100. </div><div class="MsoNormal">2. Hoskinson RM, Rigby RD, Mattner PE, Huynh VL, </div><div class="MsoNormal">D'Occhio M, Neish A, et al. Vaxstrate: an anti reproductive vaccine for cattle. Aust J Biotechnol. </div><div class="MsoNormal">1990;4(3):166-70, 176. </div><div class="MsoNormal">3. Prendiville DJ, Enright WJ, Crowe MA, Vaughan L, </div><div class="MsoNormal">Roche JF. Immunization of prepubertal beef heifers </div><div class="MsoNormal">against gonadotropin-releasing hormone: immune, </div><div class="MsoNormal">estrus, ovarian, and growth responses. J Anim Sci. </div><div class="MsoNormal">1995;73(10):3030-7. </div><div class="MsoNormal">4. Bonneau M, Enright WJ. Immunocastration in cattle </div><div class="MsoNormal">and pigs. Livest Prod Sci. 1995;42(2-3):193-200. </div><div class="MsoNormal">5. Robbins SC, Jelinski MD, Stotish RL. Assessment </div><div class="MsoNormal">of the immunological and biological efficacy of two </div><div class="MsoNormal">different doses of a recombinant GnRH vaccine in </div><div class="MsoNormal">domestic male and female cats (Felis catus). J </div><div class="MsoNormal">Reprod Immunol. 2004;64(1-2):107-19. </div><div class="MsoNormal">6. Miller LA, Johns BE, Killian GJ. Immunocontraception of white-tailed deer with GnRH vaccine. Am J </div><div class="MsoNormal">Reprod Immunol. 2000;44(5):266-74. </div><div class="MsoNormal">Table 3. Percentage of normal and abnormal sperm morphology in the experimental and control groups of male mice, Mus musculus, after different intervals</div><div class="MsoNormal">Days Groups </div><div class="MsoNormal">Normal </div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>(%)</div><div class="MsoNormal">Abnormal (%) </div><div class="MsoNormal">Pin head </div><div class="MsoNormal">Large </div><div class="MsoNormal">head </div><div class="MsoNormal">Oval </div><div class="MsoNormal">head </div><div class="MsoNormal">Double </div><div class="MsoNormal">head </div><div class="MsoNormal">Head less Bent neck </div><div class="MsoNormal">Looping </div><div class="MsoNormal">mid piece </div><div class="MsoNormal">Coiled tail </div><div class="MsoNormal">Double </div><div class="MsoNormal">tailed </div><div class="MsoNormal">Tail-less </div><div class="MsoNormal">30<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">Control<span style="mso-spacerun: yes;"> </span>58.44±2.12 5.0±0.35 1.0±0.35 4.0±0.79 1.2±0.65 4.0±1.17 3.0±0.86 4.4±1.60 1.6±0.30 0.0±0.0 2.5±1.00 </div><div class="MsoNormal">GnRHBSA </div><div class="MsoNormal">27.77±0.78</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>a</div><div class="MsoNormal">8.4±1.03<span style="mso-spacerun: yes;"> </span>5.0±0.79<span style="mso-spacerun: yes;"> </span>5.80±1.29<span style="mso-spacerun: yes;"> </span>2.2±0.74<span style="mso-spacerun: yes;"> </span>5.8±1.08<span style="mso-spacerun: yes;"> </span>6.4±1.03<span style="mso-spacerun: yes;"> </span>6.2±0.65<span style="mso-spacerun: yes;"> </span>2.4±0.75<span style="mso-spacerun: yes;"> </span>2.2±0.96<span style="mso-spacerun: yes;"> </span>5.4±1.15 </div><div class="MsoNormal">GnRHBSA+ KA </div><div class="MsoNormal">24.00±1.22</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>ab*</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>7.6±0.57 4.20±0.65 6.4±1.03 2.4±0.75 8.6±0.90 5.6±1.3 6.5±2.19 1.80±0.24 1.66±0.51 2.5±0.75 </div><div class="MsoNormal">60<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">Control<span style="mso-spacerun: yes;"> </span>64.00±1.41 5.4±0.57 4.2±0.65 3.4±0.57 0.60±0.00 5.0±1.36 3.4±0.57 4.2±0.65 2.5±0.55 1.33±0.51 0.80±0.14 </div><div class="MsoNormal">GnRHBSA </div><div class="MsoNormal">23.20±1.16 a<span style="mso-spacerun: yes;"> </span>11.2±0.65<span style="mso-spacerun: yes;"> </span>10.20±1.74<span style="mso-spacerun: yes;"> </span>7.20±0.50<span style="mso-spacerun: yes;"> </span>2.60±0.90<span style="mso-spacerun: yes;"> </span>7.80±0.65<span style="mso-spacerun: yes;"> </span>9.4±1.15<span style="mso-spacerun: yes;"> </span>10.80±1.38<span style="mso-spacerun: yes;"> </span>4.0±0.70<span style="mso-spacerun: yes;"> </span>2.00±0.00<span style="mso-spacerun: yes;"> </span>3.5±0.87 </div><div class="MsoNormal">GnRHBSA+ KA </div><div class="MsoNormal">20.65±0.94 a 10.80±0.45 6.4±0.59 7.4±0.90 0.00±0.00 11.80±1.43 10.00±1.76 9.60±0.51 2.50±0.48 3.0±1.11 5.80±2.38 </div><div class="MsoNormal">90<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">Control<span style="mso-spacerun: yes;"> </span>67.10±1.74 4.5±0.65 2.60±1.03 2.2±0.41 0.00±0.00 3.401.71 2.60±0.90 1.60±0.83 0.00±0.00 2.60±1.03 1.0±0.21 </div><div class="MsoNormal">GnRHBSA </div><div class="MsoNormal">14.24±0.48 a<span style="mso-spacerun: yes;"> </span>13.60±1.15<span style="mso-spacerun: yes;"> </span>5.80±0.93<span style="mso-spacerun: yes;"> </span>6.0±1.00<span style="mso-spacerun: yes;"> </span>1.20±0.65<span style="mso-spacerun: yes;"> </span>10.40±0.75<span style="mso-spacerun: yes;"> </span>12.0±0.79<span style="mso-spacerun: yes;"> </span>17.80±1.94<span style="mso-spacerun: yes;"> </span>2.50±1.15<span style="mso-spacerun: yes;"> </span>1.0±0.25<span style="mso-spacerun: yes;"> </span>8.0±0.65 </div><div class="MsoNormal">GnRHBSA+ KA </div><div class="MsoNormal">12.72±0.23 ab 13.20±1.19 8.80±0.96 5.80±1.55 2.2±0.96 13.40±1.03 9.5±2.07 10.80±1.29 3.0±0.79 2.5±0.83 11.0±1.76 </div><div class="MsoNormal">120<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">Control<span style="mso-spacerun: yes;"> </span>72.00±1.66 2.60±0.41 2.20±0.39 1.0±0.50 0.00±0.00 2.80±1.29 1.20±0.54 2.0±0.44 1.00±0.00 0.00±0.00 2.5±1.15 </div><div class="MsoNormal">GnRHBSA </div><div class="MsoNormal">10.33±0.25</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>a</div><div class="MsoNormal">12.80±1.55<span style="mso-spacerun: yes;"> </span>7.00±0.79<span style="mso-spacerun: yes;"> </span>6.00±0.79<span style="mso-spacerun: yes;"> </span>2.80±0.96<span style="mso-spacerun: yes;"> </span>16.00±1.36<span style="mso-spacerun: yes;"> </span>17.20±0.96<span style="mso-spacerun: yes;"> </span>20.60±1.95<span style="mso-spacerun: yes;"> </span>5.00±1.11<span style="mso-spacerun: yes;"> </span>2.80±0.41<span style="mso-spacerun: yes;"> </span>9.50±1.68 </div><div class="MsoNormal">GnRHBSA+ KA </div><div class="MsoNormal">7.95±0.40</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>ab</div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span>14.60±1.03 11.00±0.79 7.20±0.82 3.80±0.96 17.60±1.07 15.00±1.83 14.25±2.21 4.60±1.15 4.0±1.17 12.50±0.65 </div><div class="MsoNormal">Mean ± SEM of five animals (Accuracy of calculation up to two decimal digits) </div><div class="MsoNormal">a = Significant difference with the controls in the same column (p< 0.01)<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">b = Significant difference with GnRH-BSA groups in the same column (p< 0.01) </div><div class="MsoNormal">* = Significant differences (p< 0.05)<span style="mso-spacerun: yes;"> </span>J Reprod Infertil, Vol 12, No 1, Jan/ Mar 2011 </div><div class="MsoNormal"><span style="mso-spacerun: yes;"> </span><span style="mso-spacerun: yes;"> </span>Ganaie JA, et al.<span style="mso-spacerun: yes;"> </span>JRI</div><div class="MsoNormal">7</div><div class="MsoNormal">7. Simms MS, Scholfield DP, Jacobs E, Michaeli D, </div><div class="MsoNormal">Broome P, Humphreys JE, et al. Anti-GnRH antibodies can induce castrate levels of testosterone in </div><div class="MsoNormal">patients with advanced prostate cancer. Br J Cancer. </div><div class="MsoNormal">2000;83(4):443-6. </div><div class="MsoNormal">8. Kumar N, Savage T, DeJesus W, Tsong YY, Didolkar A, Sundaram K. Chronic toxicity and reversibility of antifertility effect of immunization against </div><div class="MsoNormal">gonadotropin-releasing hormone in male rats and </div><div class="MsoNormal">rabbits. Toxicol Sci. 2000;53(1):92-9. </div><div class="MsoNormal">9. Bhadauria<span style="mso-spacerun: yes;"> </span>H.<span style="mso-spacerun: yes;"> </span>Gomutra-Ek<span style="mso-spacerun: yes;"> </span>Chamatkari<span style="mso-spacerun: yes;"> </span>Aushadhi </div><div class="MsoNormal">(Cow urine- A Magical therapy). Vish Ayur Patrika. </div><div class="MsoNormal">2002;5:71-4. </div><div class="MsoNormal">10. Chauhan RS, Singh BP, Singhal LK. Immunomodulation with kamdhenu ark in mice. J Immunol </div><div class="MsoNormal">Immunopathol. 2001;3(1):74-7. </div><div class="MsoNormal">11. Garg N, Chauhan RS, Kumar A. Assessing the </div><div class="MsoNormal">effect of cow urine on immunity of white leghorn </div><div class="MsoNormal">layers. International Society for Animal Hugges </div><div class="MsoNormal">(ISAH). 2005;2:81-3. </div><div class="MsoNormal">12. Mathivanan R, Kalaiarasi K. Panchagavya and </div><div class="MsoNormal">Andrographis paniculata as alternatives to antibiotic growth promoters on haematological, serum </div><div class="MsoNormal">biochemical parameters and immune status of </div><div class="MsoNormal">broilers. J Poult Sci. 2007;44(2):198-204. </div><div class="MsoNormal">13. Prasad MR, Chinoy NJ, Kadam KM. Changes in </div><div class="MsoNormal">succinic dehydrogenase levels in the rat epididymis </div><div class="MsoNormal">under normal and altered<span style="mso-spacerun: yes;"> </span>physiologic conditions. </div><div class="MsoNormal">Fertil Steril. 1972;23(3):186-90. </div><div class="MsoNormal">14. Highland HN, Rao MV, Chinoy NJ, Shah VC. Analysis of the functional and nuclear integrity of </div><div class="MsoNormal">human spermatozoa. Int J Fertil. 1991;36(1):43-7. </div><div class="MsoNormal">15. Esbenshade KL, Britt JH. Active immunization of </div><div class="MsoNormal">gilts against gonadotropin-releasing hormone: effects on secretion of gonadotropins, reproductive </div><div class="MsoNormal">function, and responses to agonists of gonadotropin-releasing hormone. Biol Reprod. 1985;33 </div><div class="MsoNormal">(3):569-77. </div><div class="MsoNormal">16. Johnson HE, DeAvila DM, Chang CF, Reeves JJ. </div><div class="MsoNormal">Active immunization of heifers against luteinizing </div><div class="MsoNormal">hormone-releasing hormone, human chorionic </div><div class="MsoNormal">gonadotropin and bovine luteinizing hormone. J </div><div class="MsoNormal">Anim Sci. 1988;66(3):719-26. </div><div class="MsoNormal">17. Meloen RH, Turkstra JA, Lankhof H, Puijk WC, </div><div class="MsoNormal">Schaaper WM, Dijkstra G, et al. Efficient immunecastration of male piglets by immunoneutralization </div><div class="MsoNormal">of GnRH using a new GnRH-like peptide. Vaccine. </div><div class="MsoNormal">1994;12(8):741-6. </div><div class="MsoNormal">18. Grizzle TB, Esbenshade KL, Johnson BH. Active </div><div class="MsoNormal">immunization of boars against gonadotrop in releasing hormone. I. Effects on reproductive parameters. Theriogenology. 1987;27(4):571-80. </div><div class="MsoNormal">19. Dowsett KF, Pattie WA, Knott LM, Jackson AE, </div><div class="MsoNormal">Hoskinson RM, Rigby RP, et al. A preliminary </div><div class="MsoNormal">study of immunological castration in colts. J </div><div class="MsoNormal">Reprod Fertil Suppl. 1991;44:183-90. </div><div class="MsoNormal">20. McLachlan RI, Wreford NG, Tsonis C, De Kretser </div><div class="MsoNormal">DM, Robertson DM. Testosterone effects on </div><div class="MsoNormal">spermatogenesis in the gonadotropin-releasing hormone-immunized rat. Biol Reprod. 1994;50(2): </div><div class="MsoNormal">271-80. </div><div class="MsoNormal">21. Cook RB, Popp JD, Kastelic JP, Robbins S, Harland R. The effects of active immunization against </div><div class="MsoNormal">gnRH on testicular development, feedlot performance, and carcass characteristics of beef bulls. J </div><div class="MsoNormal">Anim Sci. 2000;78(11):2778-83. </div><div class="MsoNormal">22. Janett F, Stump R, Burger D, Thun R. Suppression </div><div class="MsoNormal">of testicular function and sexual behavior by vaccination against GnRH (Equity) in the adult stallion. Anim Reprod Sci. 2009;115(1-4):88-102. </div><div class="MsoNormal">23. Levy JK, Miller LA, Cynda Crawford P, Ritchey </div><div class="MsoNormal">JW, Ross MK, Fagerstone KA. GnRH immunecontraception of male cats. Theriogenology. 2004; </div><div class="MsoNormal">62(6):1116-30. </div><div class="MsoNormal">24. Ross MK, Miller LA, Crawford PC, Ritchey JW, </div><div class="MsoNormal">Fagerstone KA. GnRH<span style="mso-spacerun: yes;"> </span>immunocontraception in </div><div class="MsoNormal">cats. In: Baker H, Boyle S, Griffin B, editors. Proceedings of the 2004 ACCD International Symposium on Non-surgical Methods for Pet Population </div><div class="MsoNormal">Control; 2004 June 24-27; Denver, Colorado, Belle </div><div class="MsoNormal">Court (Portland): ACCD Press; 2005. p.113-5.<span style="mso-spacerun: yes;"> </span></div><div class="MsoNormal">25. Prabhakar K, Singh GK, Chauhan RS, Singh DD. </div><div class="MsoNormal">Effect of cow urine on lymphocyte proliferation in </div><div class="MsoNormal">developing stages of chicks. Indian Cow. 2004;1 </div><div class="MsoNormal">(2):3-5. </div><div class="MsoNormal">26. Kumar R, Chauhan RS, Singhal LK, Singh AK, </div><div class="MsoNormal">Singh DD. A comparative study on immunostimulatory effects of Kamdhenu Ark and Vasant Kusumakar in mice. J Immunol Immunopathol. 2002;4 </div><div class="MsoNormal">(1-2):104-6. </div><div class="MsoNormal">27. Garg N, Chauhan RS. Kamdhenu ark changes </div><div class="MsoNormal">humoral immunity in rat. In: National Symposium </div><div class="MsoNormal">on Molecular Biology in India- A Post Graduate </div><div class="MsoNormal">Update; 2003 Jan 18, Gwalior, India, Gwalior </div><div class="MsoNormal">(Madhya Pradesh): Cancer Hospital and Research </div><div class="MsoNormal">Institute; 2003. p. 98. </div><div class="MsoNormal">28. Chauhan RS, Singh DD, Singhal LK, Kumar R. </div><div class="MsoNormal">Effect of cow urine on interleukin-1 and 2. J </div><div class="MsoNormal">Immunol Immunopathol. 2004;6(1):38-9. </div><div class="MsoNormal">29. Ganaie JA, Shrivastava VK. Effects of gonadotropin releasing hormone conjugate immunization </div><div class="MsoNormal">and bioenhancing role of Kamdhenu ark on estrous </div><div class="MsoNormal">cycle serum estradiol and progesterone levels in </div><div class="MsoNormal">female Mus musculus. Iran J Reprod Med. 2010;8 </div><div class="MsoNormal">(2):70-5.<span style="mso-spacerun: yes;"> </span></div><br />
</div>SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-53541048322570443322011-05-09T08:22:00.000-07:002011-05-09T08:22:37.350-07:00About Cancer Treatment<div dir="ltr" style="text-align: left;" trbidi="on"><h3 class="post-title entry-title"> <b><a href="http://kamdhenudham.blogspot.com/2010/01/about-cancer-treatment.html">About Cancer Treatment</a></b> </h3><div class="post-header"> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">Jorge Valdés Romo , Said about her wife</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">Gopa's Pita Ji wrote:</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;"><br />
</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">Dear Doctor:</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;"><br />
</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">Patiente Name: María Skarica Zúñiga.</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">On 18th August I sent info regarding the improving conditions of Maria after following the treatment after surgery. End October has been taken Thoracic X-ray, Ultrasound and Mammography.</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">Yesterday we showed the reports to the Doctor and he found them so good that he indicated a new control after 6 months. And he reduced the calcium dosage to one time every three months injection.</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;"><br />
</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">You may imagine how happy we are. She feel healthy and without any side-effect of medicines or symptoms of cancer, osteoporosis or any other sickness.</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;"><br />
</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">Our consultation now is medicines and in which dosage should she continue taking according the new reports. We expect anxiously your reply.</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;"><br />
</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">Greeting you attentively,</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">Jorge Valdes Romo.</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">Santiago - Chile, South America.</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;"><br />
</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;"><br />
</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">Estimado doctor:</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;"><br />
</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">Con fecha 18 de agosto recién pasado le informé el estado de María luego de haber seguido sus indicaciones para el tratamiento postoperatorio. A fines de octubre se tomó radiografía de torax, ecotomografía y mamografía, de los que le adjunto copia de sus informes. Ayer le llevamos al médico alópata que le controla estos mismo informes y los encontró tan buenos que le indicó nuevo control en seis meses más y le redujo la dosis de calcio a una vez cada tres meses.</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;"><br />
</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">Podrá imaginarse lo contento que estamos. Ella se siente sana y sin ninguna secuela de la enfermedad. Nuestra consulta es qué remedios y en qué cantidad debe continuar tomando de acuerdo al resultado de los informes. Con ansia esperamos su respuesta. Lo saluda muy atentamente.</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;"><br />
</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">--</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">Jorge Valdés Romo</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;"><br />
</span></b> </div><div style="color: blue; font-family: Arial,Helvetica,sans-serif;"><b><span style="font-size: x-small;">Desde Santiago de Chile - La paciente es María Skarica Zúñiga</span></b> </div><b><span style="font-size: x-small;"></span></b></div>SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-42045620632208446202011-02-14T03:23:00.000-08:002011-02-14T03:23:11.267-08:00Innaguration programme of KAMDHENUhospital<div dir="ltr" style="text-align: left;" trbidi="on">Coming-02-march-2011(8-00 AM)</div>SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-90857052052016952052010-12-27T22:09:00.000-08:002010-12-27T22:09:33.975-08:00To stay in resort 1 US $ per day (24 Hours)<span class="Apple-style-span" style="color: #990000;"><span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;">Dear Friends, </span><br />
<span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;"></span><br />
<span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;">We have built nice resort in a true natural ways , The place is in Balangir district of Orissa of India . It is quite far away from crowded population and pollution of carbon and noise , The resort is in Mountain Provided with all basic necessity , We will arrange utensils and everything if the Guests wanted to prepare food them-self otherwise we will provide the food twice in a day at the cost of only 1 $ each time , So guest have to pay just 3 $ in a day including food and accommodation , No hidden cost , No tax , no extra charges . Internet Facilities is also provided at an Additional cost . So guest no need to rush to somewhere else to look for the internet . We are encouraging Urban peoples to experience the beauty of village life at a quite affordable price . </span><br />
<span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;"></span><br />
<span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;">We support green technology hence we are in the process to install wind-turbine to generate the electricity instead of depending upon traditional electricity . </span><br />
<span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;"></span><br />
<span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;">This place would be quite suitable for those enthusiastic/writers/thinkers and who wants to get away from city crowded life and really wants to need peace full time with out any disturbance with all basic necessity at affordable price . Nearby the resort there is small Ayurveda free treatment center is also there , Cancer , diabetic and other chronic diseases can be cured at a quite affordable prices .</span><br />
<span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;"></span><br />
<span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;">We have built a nice resort in a true natural way it is located in Bolangir district of Orissa of India , the place is quite far away from crowded population , Per day we charge just 1 $ and 2 $ for food , Internet facility would be available on additional cost . Please come and stay for months together at affordable price . </span><br />
<span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;"></span><br />
<span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;">If you have any query/request to book the place please email to </span><span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;"><a href="mailto:info@sevika.org" target="_blank">info@sevika.org</a></span><span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;"> .The contact no is </span><span style="background-color: transparent; font-family: 'Times New Roman'; font-size: 12pt; font-style: normal; font-weight: normal; text-decoration: underline; vertical-align: baseline; white-space: pre;">+918018911018 +919439422804 </span><br />
<span style="background-color: transparent; font-family: 'Times New Roman'; font-size: 12pt; font-style: normal; font-weight: normal; text-decoration: underline; vertical-align: baseline; white-space: pre;"></span><br />
<span style="background-color: transparent; font-family: 'Times New Roman'; font-size: 12pt; font-style: normal; font-weight: normal; text-decoration: underline; vertical-align: baseline; white-space: pre;">400 Words Contents . </span><br />
<span style="background-color: transparent; font-family: 'Times New Roman'; font-size: 12pt; font-style: normal; font-weight: normal; text-decoration: underline; vertical-align: baseline; white-space: pre;"></span><br />
<span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;">We have built a nice resort in a true natural way it is located in Bolangir district of Orissa of India , the place is quite far away from crowded population , Per day we charge just 1 $ and 2 $ for food , Internet facility would be available on additional cost . Please come and stay for months together at affordable price . </span><br />
<span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;"></span><br />
<span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;">If you have any query/request to book the place please email to </span><span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;"><a href="mailto:info@sevika.org" target="_blank">info@sevika.org</a></span><span style="background-color: transparent; font-family: Arial; font-size: 13pt; font-style: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre;"> .The contact no is </span><span style="background-color: transparent; font-family: 'Times New Roman'; font-size: 12pt; font-style: normal; font-weight: normal; text-decoration: underline; vertical-align: baseline; white-space: pre;">+918018911018 + 919439422804 </span></span>SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-5772119999002142822010-12-01T06:13:00.000-08:002010-12-01T06:13:08.532-08:00HIV & AIDS TREATMENT !<div style="color: purple;">PLZ CONTACT:</div><div style="color: purple;">KAMDHENU PANCHAGAVYA RESEARCH CENTRE(<b style="color: orange;">HOSPITAL</b>),PATNAGARH,ORISSA,INDIA.</div><span style="color: purple;">MOB.NO-</span> <span style="color: blue;">+91 8018911018,9439422804.</span>SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-15364914120699639972010-12-01T06:08:00.000-08:002010-12-01T06:08:21.828-08:00HIV & AIDS<div class="box bFull"><div class="box bFull"> <h2>What is AIDS?</h2>AIDS stands for: <span class="def"><b>A</b>cquired <b>I</b>mmune <b>D</b>eficiency <b>S</b>yndrome</span><br />
AIDS is a medical condition. A person is diagnosed with AIDS when their immune system is too weak to fight off infections.<br />
Since <a href="http://www.avert.org/history-science.htm">AIDS was first identified</a> in the early 1980s, an unprecedented number of people have been affected by the <a href="http://www.avert.org/aids-hiv.htm">global AIDS epidemic</a>. Today, there are an estimated 33.3 million people living with HIV and AIDS worldwide.<br />
</div><h2>What causes AIDS?</h2>AIDS is caused by <a href="http://www.avert.org/hiv.htm">HIV</a>.<br />
HIV is a virus that gradually attacks immune system cells. As HIV progressively damages these cells, the body becomes more vulnerable to infections, which it will have difficulty in fighting off. It is at the point of very advanced HIV infection that a person is said to have AIDS. It can be years before HIV has damaged the immune system enough for AIDS to develop.<br />
<h2>What are the symptoms of AIDS?</h2>A person is diagnosed with AIDS when they have developed an AIDS related condition or symptom, called an <a href="http://www.avert.org/hiv-opportunistic-infections.htm">opportunistic infection</a>, or an AIDS related cancer. The infections are called ‘opportunistic’ because they take advantage of the opportunity offered by a weakened immune system.<br />
It is possible for someone to be <a href="http://www.avert.org/stages-hiv-aids.htm">diagnosed with AIDS</a> even if they have not developed an opportunistic infection. AIDS can be diagnosed when the number of immune system cells (CD4 cells) in the blood of an HIV positive person drops below a certain level.<br />
<h2>Is there a cure for AIDS?</h2>Worryingly, many people think there is a 'cure' for AIDS - which makes them feel safer, and perhaps take risks that they otherwise wouldn’t. However, there is still no <a href="http://www.avert.org/cure-for-aids.htm">cure for AIDS</a>. The only way to stay safe is to be aware of <a href="http://www.avert.org/can-you-get-hiv-aids.htm">how HIV is transmitted</a> and how to <a href="http://www.avert.org/prevent-hiv.htm">prevent HIV infection</a>.<br />
<h2>How many people have died from AIDS?</h2>Since the first cases of AIDS were identified in 1981, more than 25 million people have died from AIDS. An estimated 1.8 million people died as a result of AIDS in 2009 alone.<br />
Although there is no cure for AIDS, HIV infection can be prevented, and those living with HIV can take antiretroviral drugs to delay the onset of AIDS. However, in many countries across the world access to prevention and treatment services is limited. Global leaders have pledged to work towards <a href="http://www.avert.org/universal-access.htm" target="_self">universal access</a> to HIV prevention and care, so that millions of deaths can be averted.<br />
<h2>How is AIDS treated?</h2><div class="photo boxRight"><a href="http://www.avert.org/aids-picture.php?photo_id=3086"><img alt="A community health worker gives an HIV positive patient antiretroviral drugs, Kenya" border="0" src="http://www.avert.org/media/photos/2810.jpg" width="200" /><span style="width: 190px;">A community health worker gives an HIV positive patient antiretroviral drugs, Kenya </span></a></div><a href="http://www.avert.org/treatment.htm">Antiretroviral treatment</a> can prolong the time between HIV infection and the onset of AIDS. Modern combination therapy is highly effective and someone with HIV who is taking treatment could live for the rest of their life without developing AIDS.<br />
An AIDS diagnosis does not necessarily equate to a death sentence. Many people can still benefit from <a href="http://www.avert.org/antiretroviral.htm">starting antiretroviral therapy</a> even once they have developed an AIDS defining illness. Better treatment and prevention for opportunistic infections have also helped to improve the quality and length of life for those diagnosed with AIDS.<br />
Treating some opportunistic infections is easier than others. Infections such as herpes zoster and candidiasis of the mouth, throat or vagina, can be managed effectively in most environments. On the other hand, more complex infections such as toxoplasmosis, need advanced medical equipment and infrastructure, which are lacking in many resource-poor areas.<br />
It is also important that treatment is provided for <a href="http://www.avert.org/aids-pain.htm">AIDS related pain</a>, which is experienced by almost all people in the very advanced stages of HIV infection.<br />
<h2 class="clear">Why do people still develop AIDS today?</h2>Even though antiretroviral treatment can prevent the onset of AIDS in a person living with HIV, many people are still diagnosed with AIDS today. There are four main reasons for this:<br />
<ul><li>In many resource-poor countries <a href="http://www.avert.org/universal-access.htm">antiretroviral treatment is not widely available</a>. Even in wealthier countries, such as America, many individuals are not covered by health insurance and cannot afford treatment. </li>
<li>Some people who became infected with HIV in the early years of the epidemic before combination therapy was available, have subsequently developed drug resistance and therefore have limited treatment options.</li>
<li>Many people are never <a href="http://www.avert.org/testing.htm">tested for HIV</a> and only become aware they are infected with the virus once they have developed an AIDS related illness. These people are at a higher risk of mortality, as they tend to respond less well to treatment at this stage.</li>
<li>Sometimes people taking treatment are unable to <a href="http://www.avert.org/arv-treatment.htm">adhere</a> to, or tolerate the <a href="http://www.avert.org/aids-drug-side-effects.htm">side effects</a> of drugs. </li>
</ul><h2>Caring for a person with AIDS</h2>In the later stages of AIDS, a person will need <a href="http://www.avert.org/palliative-care.htm">palliative care</a> and <a href="http://www.avert.org/emotional-needs-support.htm">emotional support</a>. In many parts of the world, friends, family and AIDS organisations provide <a href="http://www.avert.org/aids-home-care.htm">home based care</a>. This is particularly the case in countries with high HIV prevalence and overstretched healthcare systems.<br />
<a href="http://www.avert.org/palliative-care.htm">End of life care</a> becomes necessary when a person has reached the very final stages of AIDS. At this stage, preparing for death and open discussion about whether a person is <a href="http://www.avert.org/die.htm">going to die</a> often helps in addressing concerns and ensuring final wishes are followed.<br />
<h2>The global AIDS epidemic</h2>Around 2.6 million people became infected with HIV in 2009. Sub-Saharan <a href="http://www.avert.org/hiv-aids-africa.htm">Africa</a> has been hardest hit by the epidemic; in 2009 over two-thirds of AIDS deaths were in this region.<br />
<div class="photo boxLeft"><a href="http://www.avert.org/aids-picture.php?photo_id=3089"><img alt="Parc de l'espoir - AIDS Memorial Park in Montreal, Canada" border="0" src="http://www.avert.org/media/photos/2813.jpg" width="300" /><span style="width: 290px;">Parc de l'espoir - AIDS Memorial Park in Montreal, Canada </span></a></div><a href="http://www.avert.org/teens-sex-questions.htm">Asia</a>, HIV and AIDS causes a greater loss of productivity than any other disease. An adult’s most productive years are also their most reproductive and so many of the age group who have died from AIDS have left children behind. In sub-Saharan Africa the AIDS epidemic has <a href="http://www.avert.org/aids-orphans.htm">orphaned</a> nearly 15 million children.<br />
In recent years, the response to the epidemic has been intensified; in the past ten years in low- and middle-income countries there has been a 6-fold increase in <a href="http://www.avert.org/aids-funding.htm">spending for HIV and AIDS</a>. The number of people on antiretroviral treatment has increased, the annual number of AIDS deaths has declined, and the global percentage of people infected with HIV has stabilised.<br />
However, recent achievements should not lead to complacent attitudes. In all parts of the world, people living with HIV still face AIDS related <a href="http://www.avert.org/hiv-aids-stigma.htm">stigma and discrimination</a>, and many people still cannot access sufficient HIV treatment and care. In <a href="http://www.avert.org/america.htm">America</a> and some countries of <a href="http://www.avert.org/aids-hiv-asia-europe.htm">Western and Central</a> and <a href="http://www.avert.org/aids-russia.htm">Eastern Europe</a>, infection rates are rising, indicating that <a href="http://www.avert.org/prevent-hiv.htm">HIV prevention</a> is just as important now as it ever has been. Prevention efforts that have proved to be effective need to be scaled-up and treatment targets reached. Commitments from national governments right down to the community level need to be intensified and subsequently met, so that one day the world might see an end to the global AIDS epidemic.<br />
<h2>Learn more about HIV and AIDS</h2>In addition to the hundreds of informative pages about HIV and AIDS, the AVERT website has interactive ways to learn more about HIV and AIDS.<br />
<ul><li>The AVERT <a href="http://www.avert.org/hiv-aids-game.htm">AIDS Game</a> is a great way to see how much you know about HIV and AIDS.</li>
<li>You can test your knowledge of HIV and AIDS by trying one of our online <a href="http://www.avert.org/hivquiz.htm">quizzes</a>.</li>
<li>Our <a href="http://www.avert.org/photo-gallery">photo gallery</a> has hundreds of HIV and AIDS related photos from around the world.</li>
<li>The AVERT <a href="http://www.avert.org/videos">video gallery</a> has a number of short videos related to HIV and AIDS.</li>
<li style="text-align: left;">Finally, you can read <a href="http://www.avert.org/stories.htm">stories</a> that have been sent to us from people who are either living with HIV or who have been affected by HIV and AIDS.</li>
</ul></div>SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-66011121627757746172010-06-09T07:36:00.001-07:002010-06-09T07:36:59.249-07:00KAMDHENU HEALTH CARE CENTRE<blockquote><blockquote><span style="font-size: x-large;"><b><span style="background-color: orange; color: red;">Kamdhenu Health Care Centre</span></b></span></blockquote></blockquote><div style="font-family: Georgia,"Times New Roman",serif;"><span style="font-size: x-large;"><a name='more'></a></span></div><blockquote><blockquote><blockquote><blockquote><div style="color: #660000;"><b><span style="background-color: #38761d; font-size: large;"><span style="font-family: Arial,Helvetica,sans-serif;">under cunstruction</span></span> </b></div></blockquote></blockquote></blockquote></blockquote><div style="background-color: #8e7cc3; color: yellow;"><b>at SEVIKA ASRAM,turlamal,po balipata,near patnagarh(orissa)</b></div><div style="background-color: #8e7cc3; color: yellow;"><b>We need critical and chronic patients who is sufferer from General medicines and injections !</b></div><blockquote><blockquote><blockquote><blockquote><blockquote><blockquote><div style="color: #660000;"><b style="background-color: cyan;">plz contact :</b> </div></blockquote></blockquote></blockquote></blockquote></blockquote></blockquote><div style="background-color: yellow; color: purple;"> <span style="color: #990000; font-size: large;"><b> <span style="color: lime;">SEVIKA</span> ASRAM</b></span><b style="color: #990000;"> (<span style="color: #cc0000;">kamdhenu dham</span>)</b></div><div style="text-align: left;"><b style="background-color: yellow;"> At-turlamal, Po-balipata, Via-patnagarh, Dist-balangir</b><b style="background-color: yellow; color: #990000;">, Orissa</b><b style="background-color: yellow; color: #990000;">, 767025.</b></div>SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com1tag:blogger.com,1999:blog-4523673594741218645.post-19732392221960712772010-02-08T05:34:00.000-08:002010-02-08T05:34:17.795-08:00CANCER PROFILE<div style="text-align: center;">MY CANCER PROFILE</div><br />
<br />
NAME-María Skarica Zúñiga. <br />
Sex-Female<br />
Date of birth/Age-<br />
1st date of cancer Detect<br />
Symptoms<br />
Disease<br />
Date About your 1st treatment <br />
Date About your2nd treatment <br />
Date About your 3rd treatment <br />
Date How did you know about kamdhenu Ayurvedic treatment? <br />
Date date of first (Ayurvedic kamdhenu) treatment <br />
Date Your comments about first treatment <br />
Date After 6 months <br />
<span style="font-size: xx-small;">Dear Doctor:</span><br />
<span style="font-size: xx-small;">Patient Name: María Skarica Zúñiga.</span><br />
<span style="font-size: xx-small;">On 18th August I sent info regarding the improving conditions of Maria after following the treatment after surgery. End October has been taken Thoracic X-ray, Ultrasound and Mammography.</span><br />
<span style="font-size: xx-small;">Yesterday we showed the reports to the Doctor and he found them so good that he indicated a new control after 6 months. And he reduced the calcium dosage to one time every three months injection.</span><br />
<span style="font-size: xx-small;">You may imagine how happy we are. She feel healthy and without any side-effect of medicines or symptoms of cancer, osteoporosis or any other sickness.</span><br />
<span style="font-size: xx-small;">Our consultation now is medicines and in which dosage should she continue taking according the new reports. We expect anxiously your reply.</span><br />
<span style="font-size: xx-small;"><br />
</span><br />
<span style="font-size: xx-small;">Greeting you attentively,</span><br />
<span style="font-size: xx-small;">Jorge Valdes Romo.</span><br />
<span style="font-size: xx-small;">Santiago - Chile, South America.</span><br />
<br />
<span style="font-size: x-small;">Date </span><br />
<span style="font-size: x-small;">Present Condition </span><br />
<span style="font-size: x-small;">Dear Doctor,</span><br />
<span style="font-size: x-small;">I am writing to u because my mom is not feeling good.</span><br />
<span style="font-size: x-small;">She is taking all ur medicines but she was like 10 days without taking because the post with them was not arriving.</span><br />
<span style="font-size: x-small;">Can u suggest something about?</span><br />
<span style="font-size: x-small;">She is feeling the mouth bitter so she cannot eat fruits nor vegetables. She feels fatigue and the sensation of emptiness on stomach.</span><br />
<span style="font-size: x-small;">She cannot eat sweet things.</span><br />
<span style="font-size: x-small;">So, she eating only pasta and potatos, she is getting thin.</span><br />
<span style="font-size: x-small;">She is not feeling good.</span><br />
<span style="font-size: x-small;">What do u think?</span><br />
<span style="font-size: x-small;"><br />
</span><br />
<span style="font-size: x-small;">Thanks and wait for ur reply</span><br />
<span style="font-size: x-small;"><br />
</span><br />
<span style="font-size: x-small;">gopa</span><br />
<span style="font-size: x-small;">Dear gopa,</span><br />
<span style="font-size: x-small;">Hare Krishna! </span><br />
<span style="font-size: x-small;">Your mother should undergo exm.. thouroughly she has to be careful about diet . She should take juice, rice and green veg. .say no to potato, tomato and non veg. for mouth problem- </span><br />
<span style="font-size: x-small;">1.She should take curd with salt or / and Buttermilk once a day.</span><br />
<span style="font-size: x-small;">2. She has to chew a bit of ginger with very little salt ½’n hour before the lunch.</span><br />
<span style="font-size: x-small;">3. Wheat grass juice 100 ml. morning (for 15 days).</span><br />
<span style="font-size: x-small;">Medicine-</span><br />
<span style="font-size: x-small;">1.Yogendra Rash(most powerful for energy with amazing immunity)</span><br />
<span style="font-size: x-small;">2. Khadiradi bati(for mouth problem)</span><br />
<span style="font-size: x-small;">3. Irimedadi Tail(for mouth problem)</span><br />
<span style="font-size: x-small;">4. Bhashma’s for liver Treatment </span><br />
<span style="font-size: x-small;">This medicine gives power for liver and improves diet. She has to take this medicines for 3 mounths minimium</span><br />
<span style="font-size: x-small;"><br />
</span><br />
<span style="font-size: x-small;"><br />
</span><br />
<span style="font-size: x-small;">Please write your Total Treatment of CVR Breast Cancer, and attach all your Examined Reports.</span><br />
<span style="font-size: x-small;"><br />
</span><br />
<span style="font-size: x-small;">Also give all remarkable facts and in formations related directly to the patient.</span><br />
<span style="font-size: x-small;"><br />
</span><br />
<span style="font-size: x-small;">We need to know all these in detail about the patient for examining and researching for our next step for the treatment.</span><br />
<span style="font-size: x-small;"><br />
</span><br />
<span style="font-size: x-small;">Thanks for all your cooperation and seriousness yet you have been showed with me, and aspect the same in future.</span><br />
<span style="font-size: x-small;"><br />
</span><br />
<span style="font-size: x-small;"><br />
</span><br />
<span style="font-size: x-small;"><br />
</span><br />
<span style="font-size: x-small;">With regards</span><br />
<span style="font-size: x-small;">Saradacharya.</span><br />
<span style="font-size: x-small;"><br />
</span>SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-43989524231749123632010-01-14T22:45:00.000-08:002010-01-14T22:45:20.931-08:00About Breast CancerGopa's Pita Ji wrote:<br />
<br />
Dear Doctor:<br />
<br />
Patiente Name: María Skarica Zúñiga.<br />
On 18th August I sent info regarding the improving conditions of Maria after following the treatment after surgery. End October has been taken Thoracic X-ray, Ultrasound and Mammography.<br />
Yesterday we showed the reports to the Doctor and he found them so good that he indicated a new control after 6 months. And he reduced the calcium dosage to one time every three months injection.<br />
<br />
You may imagine how happy we are. She feel healthy and without any side-effect of medicines or symptoms of cancer, osteoporosis or any other sickness.<br />
<br />
Our consultation now is medicines and in which dosage should she continue taking according the new reports. We expect anxiously your reply.<br />
<br />
Greeting you attentively,<br />
Jorge Valdes Romo.<br />
Santiago - Chile, South America.<br />
<br />
<br />
Estimado doctor:<br />
<br />
Con fecha 18 de agosto recién pasado le informé el estado de María luego de haber seguido sus indicaciones para el tratamiento postoperatorio. A fines de octubre se tomó radiografía de torax, ecotomografía y mamografía, de los que le adjunto copia de sus informes. Ayer le llevamos al médico alópata que le controla estos mismo informes y los encontró tan buenos que le indicó nuevo control en seis meses más y le redujo la dosis de calcio a una vez cada tres meses.<br />
<br />
Podrá imaginarse lo contento que estamos. Ella se siente sana y sin ninguna secuela de la enfermedad. Nuestra consulta es qué remedios y en qué cantidad debe continuar tomando de acuerdo al resultado de los informes. Con ansia esperamos su respuesta. Lo saluda muy atentamente.<br />
<br />
--<br />
Jorge Valdés Romo<br />
<br />
Desde Santiago de Chile - La paciente es María Skarica Zúñiga<br />
<br />
SaludosSEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-18509468091657194302010-01-14T22:43:00.000-08:002010-01-14T22:43:40.847-08:00historial 1 Mauricio Pereira(09.09.06_08.10.08)&historial 2 Mauricio Pereira(16.02.09_15.12.09)<meta content="text/html; charset=utf-8" http-equiv="Content-Type"></meta><meta content="Word.Document" name="ProgId"></meta><meta content="Microsoft Word 11" name="Generator"></meta><meta content="Microsoft Word 11" name="Originator"></meta><link href="file:///C:%5CDOCUME%7E1%5CSHREEH%7E1%5CLOCALS%7E1%5CTemp%5Cmsohtml1%5C01%5Cclip_filelist.xml" rel="File-List"></link><o:smarttagtype name="metricconverter" namespaceuri="urn:schemas-microsoft-com:office:smarttags"></o:smarttagtype><style>
<!--
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-style-parent:"";
margin:0pt;
margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman";
mso-ansi-language:ES;
mso-fareast-language:ES;}
@page Section1
{size:595.3pt 841.9pt;
margin:70.85pt 85.05pt 70.85pt 85.05pt;
mso-header-margin:35.4pt;
mso-footer-margin:35.4pt;
mso-paper-source:0;}
div.Section1
{page:Section1;}
-->
</style> <br />
<div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><meta content="text/html; charset=utf-8" http-equiv="Content-Type"></meta><meta content="Word.Document" name="ProgId"></meta><meta content="Microsoft Word 11" name="Generator"></meta><meta content="Microsoft Word 11" name="Originator"></meta><link href="file:///C:%5CDOCUME%7E1%5CSHREEH%7E1%5CLOCALS%7E1%5CTemp%5Cmsohtml1%5C01%5Cclip_filelist.xml" rel="File-List"></link><o:smarttagtype name="metricconverter" namespaceuri="urn:schemas-microsoft-com:office:smarttags"></o:smarttagtype><o:smarttagtype name="place" namespaceuri="urn:schemas-microsoft-com:office:smarttags"></o:smarttagtype><o:smarttagtype name="City" namespaceuri="urn:schemas-microsoft-com:office:smarttags"></o:smarttagtype><o:smarttagtype name="country-region" namespaceuri="urn:schemas-microsoft-com:office:smarttags"></o:smarttagtype><style>
<!--
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-style-parent:"";
margin:0pt;
margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman";
mso-ansi-language:ES;
mso-fareast-language:ES;}
@page Section1
{size:595.3pt 841.9pt;
margin:70.85pt 85.05pt 70.85pt 85.05pt;
mso-header-margin:35.4pt;
mso-footer-margin:35.4pt;
mso-paper-source:0;}
div.Section1
{page:Section1;}
-->
</style> <br />
</div><div class="MsoNormal" style="text-align: justify;">09-Sep-2006<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Chest CT scan.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Backgrounds of adrenal tumor surgery. No evidence of secondary locations of known primary. Elongation and aortic atheromatosis<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Bone scintigraphy.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">No evidence of secondary osseous atypia.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">09-Mar-2007<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Brain CT scan.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">No diagnostic impression.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>CT scan of abdomen and pelvis.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Control of operated right carcinoma.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Retroperitoneal mass of infiltrating nature compatible with local tumor recurrence, which compromises the suprarenal portion of inferior vena cava.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Retroperitoneal adenopathy.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Focal hepatic hypovascular lesion compatible with a secondary location.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Chest CT scan.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Multiple bilateral pulmonary nodules compatibles with secondary locations.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">After obtaining these results, I concur to Labiofam, at <st1:place w:st="on"><st1:city w:st="on">Havana</st1:city>, <st1:country-region w:st="on">Cuba</st1:country-region></st1:place>, and started on March the 30<sup>th</sup> a treatment with the Natural Toxin.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">On April the 8<sup>th</sup> I hand in to 6 monthly cycles of chemotherapy with a duration of 7 days each, on Doxorubicin, Etoposide and Cisplatin (April-September). I’m medicated with <st1:metricconverter productid="4 g" w:st="on">4 g</st1:metricconverter>. a day of Lysodern or Mitotane, which rises later to <st1:metricconverter productid="6 grams" w:st="on">6 grams</st1:metricconverter> a day. Currently I’m taking between 4-<st1:metricconverter productid="3 g" w:st="on">3 g</st1:metricconverter>. per day because it started to affect my difestion and quality of life.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">11-Apr-2007<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Multislice computed chest tomography.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Control of lung metastasis of adrenal cancer with impressive progression (111 nodules in the right lung and <st1:metricconverter productid="72 in" w:st="on">72 in</st1:metricconverter> the left one).<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">In the right adrenal region and in close relationship with the lower vena cava, multiple heterogeneous hypodense solid formations are revealed, which compress the vein in question.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Post-surgical sequels on the chest wall.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">18-Apr-2007<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Breast ultrasound.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Suggestive finding of mild bilateral gynecomastia.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">5-Jun-2007<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Thoracic helical CT.</b> <o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Control of secondary pulmonary implants of adrenal cancer being treated. Stables in size, density and morphology in relation to the last exam on 11-Apr-2007.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Abdomen Helical CT.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Control of right renal cancer being treated. A solid nodular lesion persists, partially defined as hypodense without changes in relations to the exam on March 2007 of the segment VI of the right hepatic lobe.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">A retroperitoneal mass persists in an interaortacaval position which runs in <st1:metricconverter productid="42 mm" w:st="on">42 mm</st1:metricconverter>. length and in <st1:metricconverter productid="25 mm" w:st="on">25 mm</st1:metricconverter>. maximum transverse diameter. Partial regression is observed in relation to April 2007 (Thorax CAT).<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">No new lesions have appeared.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Small right renal cyst.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Surgical clip in relation to the right adrenal gland region.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">14-Aug-2007<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Thoracic helical CT.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Control of adrenal cancer with lung implants, stable in terms of number, distribution and size of lung nodules.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Helical CT Abdomen<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Partial regression of the retroperitoneal mass in control. It takes a well defined elongated solid nodule morphology of 19x20 mm. (length x transverse). Second posterior nodule and the findings on the right liver lobe unchanged.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">04-Oct-2007<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Computed tomography of chest, abdomen and pelvis.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Control of adrenal cancer. Stable lung metastases (Approx. 100 nodes total).<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Higher retroperitoneal nodule unchanged.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">No evidence of hepatic focal depression in this control.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">No identification of the gallbladder that should be valued according to previous background.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Simple cortical bilateral cysts.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">10-Jan-2008<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Certificate of discharge.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">History. Operated adrenal carcinoma, which develops a relapse in retroperitoneum (operative bed), liver and lungs. He completed 6 cycles of chymoptherapy with partial response (good response in the liver and stabilization of pulmonary lesions). After chemoterpay the patient is in maintenance treatment with Mitotane and medical alternative treatments (Escozul). Subsequently he has a progression of the retroperitoneal tumor which causes pain. The patient was referred for evaluation. It is estimated feasible radiotherapy to the retroperitoneal tumor which is closely related to the right kidney.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">Treatment. Modulated intensity radiotherapy to the retroperitoneum , 50 Gy in 20 fractions to the periphery of the white volume (CTV), with a dose of 60 Gy in 20 fractions to the macroscopic tumor. The dose to the right kidney and liver was kept within the tolerance levels. 4 coplanar fields where used with 5 segments each, and 18 MV X-rays. Start: 12-Dec-2007. End: 10-Jan-2008.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">Tolerance: Excellent. The patient underwent quite tired during the treatments, but noted a significant pain relief. No other adverse effects.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">16-Jan-2008<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Chest, abdomen and pelvis computed tomography.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">History of treated right adrenal cancer. Signs consistent with local relapse and secondary lung lesions, which have not suffered modifications in relations to the previous review mentioned (Approx 70 nodules total).<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Mild hepatomegaly. Signs suggestive of hepatic steatosis.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Simple bilateral cortical renal cysts.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Prostatic enlargement.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">27-Mar-2008<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Multislice computed tomography of chest and abdomen.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Background of operated right adrenal cancer and recurred locally with lung metastases in control (10 nodules recognized in the right lung and <st1:metricconverter productid="30 in" w:st="on">30 in</st1:metricconverter> the left lung). Partial but significant regression of the manifestations of basal neoplastic disease.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">07-Jul-2008<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>CT scan of abdomen and pelvis.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Stability of intra-abdominal neoplastic manifestations in relation to reference control.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Computed chest tomography.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Intrathroacic neoplastic manifestations stable (10 nodules in the left lung and <st1:metricconverter productid="25 in" w:st="on">25 in</st1:metricconverter> the right lung).<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Brain CT scan.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">With a intravenous contrast medium, does not identify vascular abnormalities of importance.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">08-Oct-2008<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Chest, abdomen and pelvis computed tomography.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">The disease is stable in relation to it’s manifestations in the chest and abdomen from the preovious study.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">(Pumonary nodules persists in numbers of <st1:metricconverter productid="10 in" w:st="on">10 in</st1:metricconverter> the right lung and <st1:metricconverter productid="25 in" w:st="on">25 in</st1:metricconverter> the left one). <o:p></o:p><br />
</div>16-Feb-2009<o:p></o:p><br />
<div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Computed tomography of chest, abdomen and pelvis.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">Radiological printing:<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Backgrounds of treated adrenal cancer. Regarding the previous study mentioned, there is an impressive progress of neoplastic disease in relation to chest manifestations (20 nodules in the right lung and <st1:metricconverter productid="25 in" w:st="on">25 in</st1:metricconverter> the left), as well as the emergence of focal hepatic injury.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>CT scan of brain.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">Radiological printing:<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Uptake nodule at left parietal subcortical level, high in convexity at parasagittal level that as a first option may correspond to the location of known primary.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">17-Feb-2009<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Skull Magnetic Resonance.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">Radiological printing:<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Nodular lesion in the left subcortical precuneus, with no other alterations. Given the background, the possibility of a secondary implant corresponds to the first diagnostic possibility.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">19-Feb-2009<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Pathological report.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">Clinical history: Distal esophageal injury. Submucosa?<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Conclusion: The morphological characteristics and immunophenotype support the diagnosis of Tumor of Esophagus Granullar Cells.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">02-Apr-2009<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Chest, Abdomen and Pelvis CT Scan.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Radiological Printing:<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">According to tomographic criteria, the pulmonary metastatic deseases remained stable compared to prior study in February 2009. There is no other data to record.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">03-Apr-2009<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Cerebral MRI.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Persistence of subcortical nodular lesion in the left precuneus projection, unchanged compared to previous exams. Given the base background, secondary locations can’t be discarded.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">23-Apr-2009<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Brain Tomography<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Diagnostic impression:<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">A history of adrenal Ca. Left uptake subcortical lesion may correspond to a secondary injury to the basic disease.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Chest. Abdomen and pelvis CT scan.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Backgrounds of suprarenal right metastatic cancer. Thoracic and abdominal manifestations are stable with respect to reference exam.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">30-Jul-2009<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Brain MRI<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Control of expansive process in the left <span style="-moz-background-clip: border; -moz-background-inline-policy: continuous; -moz-background-origin: padding; background: yellow none repeat scroll 0% 0%;">precuneo</span> with heterogenous-looking increase in volume, in relations to a previous exam of-Apr-2009.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Backgrounds of suprarenal carcinoma.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Chest, abdomen and pelvis CT scan.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Backgrounds of treated right adrenal cancer.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Evidence of significant progression of pulmonary and hepatic metastatic disease, greater than a 50% according to axial diameter criteria in relation to reference study.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;">15-Dec-2009<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Computed tomography of chest, abdomen and pelvis.<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Radiological printing:<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Backgrounds of right adrenal cancer metastatic to lung in liver, with significant progression of the pulmonary and hepatic metastasis disease.<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;"><br />
</div><div class="MsoNormal" style="text-align: justify;"><b>Brain MRI<o:p></o:p></b><br />
</div><div class="MsoNormal" style="text-align: justify;">Radiological printing:<o:p></o:p><br />
</div><div class="MsoNormal" style="text-align: justify;">Image control suggests metastases at left parietal level, which presents an important growth in relation to previous MRI pf July 2009 (lesion measures <st1:metricconverter productid="3.7 cm" w:st="on">3.7 cm</st1:metricconverter>. x <st1:metricconverter productid="2.7 cm" w:st="on">2.7 cm</st1:metricconverter>. x <st1:metricconverter productid="3.6 cm" w:st="on">3.6 cm</st1:metricconverter>).<o:p></o:p><br />
</div>SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-50803148324209069832010-01-14T22:39:00.001-08:002010-01-14T22:39:50.175-08:00Adrenal Cancer History<div class="row"> <div class="label">From: </div><div class="details"><a class="pim" href="http://help.yahoo.com/l/us/yahoo/mail/classic/context/context-07.html" id="domainkeys" target="_blank" title="This sender is DomainKeys verified"> <span class="offscreen">This sender is DomainKeys verified</span></a><div class="abook"><span class="email">"Gopa.India" <gopakumaradd@gmail.com></gopakumaradd@gmail.com></span></div><a class="pim addtoab" href="http://us.lrd.yahoo.com/_ylc=X3oDMTBsdTZpcnZpBF9TAzM5ODMwMTAyNwRhYwNhZGRBQg--/SIG=1t30423ci/**http%3A//address.mail.yahoo.com/yab%3Fv=YM%26A=m%26simp=1%26e=gopakumaradd%2540gmail.com%26fn=Gopa.India%26.done=http%253A%252F%252Fus.mc1108.mail.yahoo.com%252Fmc%252FshowMessage%253FsMid%253D4%2526filterBy%253D%2526.rand%253D1039102558%2526midIndex%253D4%2526mid%253D1_3288_AOwNw0MAAC1AS0mA9QjBPDTPK3Q%2526m%253D1_380_AOINw0MAAJY2S03yKQX7JHY2nao%25252C1_914_AOINw0MAARUQS03VQwjARGsputc%25252C1_1486_AOcNw0MAASOjS03SgQssm28rszg%25252C1_2740_AOQNw0MAABSNS0yj8wR8d3F2VaA%25252C1_3288_AOwNw0MAAC1AS0mA9QjBPDTPK3Q%25252C1_3765_AOgNw0MAAIONS0SI%25252FAcDTEdFsAg%25252C1_4212_AOwNw0MAAHk9SzR7xg4x%25252B1VqZyc%25252C1_4766_AOkNw0MAAAhuSzRnEwrluycriFw%25252C1_5326_AO0Nw0MAAYFQSy%25252FHcQCi3E0%25252F%25252BFc%25252C1_5899_AOoNw0MAAUi%25252FSyjK7gwxQRhUKXY%25252C%2526sort%253Ddate%2526order%253Ddown%2526startMid%253D0%2526hash%253Dbc2f385352863c9538c05e48284bddd4%2526.jsrand%253D1629815%2526acrumb%253D4IGysPic.Eo%2526enc%253Dauto" id="message_view_ab" title="Add sender to Contacts"> <span class="offscreen">Add sender to Contacts</span></a> </div></div><div class="row"> <div class="label">To: </div><div class="details">"Acharyaji Vrindavan" <saradchandraacharya@ymail.com></saradchandraacharya@ymail.com></div></div><div class="row"> <div class="label"> <div class="icons attachicon" title="Message contains attachments"><span class="offscreen">Message contains attachments</span></div></div><div class="details">2 Files (58KB) | <a href="http://us.mc1108.mail.yahoo.com/mc/showMessage?filterBy=&.rand=1039102558&midIndex=4&mid=1_3288_AOwNw0MAAC1AS0mA9QjBPDTPK3Q&m=1_380_AOINw0MAAJY2S03yKQX7JHY2nao%2C1_914_AOINw0MAARUQS03VQwjARGsputc%2C1_1486_AOcNw0MAASOjS03SgQssm28rszg%2C1_2740_AOQNw0MAABSNS0yj8wR8d3F2VaA%2C1_3288_AOwNw0MAAC1AS0mA9QjBPDTPK3Q%2C1_3765_AOgNw0MAAIONS0SI%2FAcDTEdFsAg%2C1_4212_AOwNw0MAAHk9SzR7xg4x%2B1VqZyc%2C1_4766_AOkNw0MAAAhuSzRnEwrluycriFw%2C1_5326_AO0Nw0MAAYFQSy%2FHcQCi3E0%2F%2BFc%2C1_5899_AOoNw0MAAUi%2FSyjK7gwxQRhUKXY%2C&sort=date&order=down&startMid=0&hash=bc2f385352863c9538c05e48284bddd4&.jsrand=1629815&acrumb=4IGysPic.Eo&enc=auto&cmd=msg.downloadall&pid[0]=2&tnef[0]=&pid[1]=3&tnef[1]=" id="downloadall" title="Download All">Download All</a></div></div><ul class="tmbnails clearfix"><li class="img"><a class="imgname" href="http://us.mc1108.mail.yahoo.com/mc/showMessage?filterBy=&.rand=1039102558&midIndex=4&mid=1_3288_AOwNw0MAAC1AS0mA9QjBPDTPK3Q&m=1_380_AOINw0MAAJY2S03yKQX7JHY2nao%2C1_914_AOINw0MAARUQS03VQwjARGsputc%2C1_1486_AOcNw0MAASOjS03SgQssm28rszg%2C1_2740_AOQNw0MAABSNS0yj8wR8d3F2VaA%2C1_3288_AOwNw0MAAC1AS0mA9QjBPDTPK3Q%2C1_3765_AOgNw0MAAIONS0SI%2FAcDTEdFsAg%2C1_4212_AOwNw0MAAHk9SzR7xg4x%2B1VqZyc%2C1_4766_AOkNw0MAAAhuSzRnEwrluycriFw%2C1_5326_AO0Nw0MAAYFQSy%2FHcQCi3E0%2F%2BFc%2C1_5899_AOoNw0MAAUi%2FSyjK7gwxQRhUKXY%2C&sort=date&order=down&startMid=0&hash=bc2f385352863c9538c05e48284bddd4&.jsrand=1629815&acrumb=4IGysPic.Eo&enc=auto&cmd=msg.scan&pid=2&tnef=&fn=historial+1+Mauricio+Pereira%2809.09.06_08.10.08%29.doc" title="historial 1 Mauricio Pereira(09.09.06_08.10.08).doc"><img alt="historial 1 Mauricio Pereira(09.09.06_08.10.08).doc" src="http://mail.yimg.com/a/i/us/pim/mail/doc.gif" />historial 1 Mauricio Pereira(09.09.06_08.10.08).doc</a></li>
<li class="img"><a class="imgname" href="http://us.mc1108.mail.yahoo.com/mc/showMessage?filterBy=&.rand=1039102558&midIndex=4&mid=1_3288_AOwNw0MAAC1AS0mA9QjBPDTPK3Q&m=1_380_AOINw0MAAJY2S03yKQX7JHY2nao%2C1_914_AOINw0MAARUQS03VQwjARGsputc%2C1_1486_AOcNw0MAASOjS03SgQssm28rszg%2C1_2740_AOQNw0MAABSNS0yj8wR8d3F2VaA%2C1_3288_AOwNw0MAAC1AS0mA9QjBPDTPK3Q%2C1_3765_AOgNw0MAAIONS0SI%2FAcDTEdFsAg%2C1_4212_AOwNw0MAAHk9SzR7xg4x%2B1VqZyc%2C1_4766_AOkNw0MAAAhuSzRnEwrluycriFw%2C1_5326_AO0Nw0MAAYFQSy%2FHcQCi3E0%2F%2BFc%2C1_5899_AOoNw0MAAUi%2FSyjK7gwxQRhUKXY%2C&sort=date&order=down&startMid=0&hash=bc2f385352863c9538c05e48284bddd4&.jsrand=1629815&acrumb=4IGysPic.Eo&enc=auto&cmd=msg.scan&pid=3&tnef=&fn=historial+2+Mauricio+Pereira%2816.02.09_15.12.09%29.doc" title="historial 2 Mauricio Pereira(16.02.09_15.12.09).doc"><img alt="historial 2 Mauricio Pereira(16.02.09_15.12.09).doc" src="http://mail.yimg.com/a/i/us/pim/mail/doc.gif" />historial 2</a></li>
</ul>SEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0tag:blogger.com,1999:blog-4523673594741218645.post-27343248758802099912010-01-14T22:37:00.000-08:002010-01-14T22:37:52.030-08:00Inmunological system<div class="msgheader"> <div class="subjectbar"><div id="divFlag"><a class="greyed" href="http://us.mc1108.mail.yahoo.com/mc/showMessage;_ylc=X3oDMTBrZ28zdG8wBF9TAzM5ODMwMTAyNwRhYwNGbGFn?sMid=5&filterBy=&.rand=1458030421&midIndex=5&mid=1_3765_AOgNw0MAAIONS0SI%2FAcDTEdFsAg&m=1_380_AOINw0MAAJY2S03yKQX7JHY2nao%2C1_914_AOINw0MAARUQS03VQwjARGsputc%2C1_1486_AOcNw0MAASOjS03SgQssm28rszg%2C1_2740_AOQNw0MAABSNS0yj8wR8d3F2VaA%2C1_3288_AOwNw0MAAC1AS0mA9QjBPDTPK3Q%2C1_3765_AOgNw0MAAIONS0SI%2FAcDTEdFsAg%2C1_4212_AOwNw0MAAHk9SzR7xg4x%2B1VqZyc%2C1_4766_AOkNw0MAAAhuSzRnEwrluycriFw%2C1_5326_AO0Nw0MAAYFQSy%2FHcQCi3E0%2F%2BFc%2C1_5899_AOoNw0MAAUi%2FSyjK7gwxQRhUKXY%2C1_6472_AO4Nw0MAAMm3SjX0Zw8HfBNlqQ0%2C&sort=date&order=down&startMid=0&hash=bc2f385352863c9538c05e48284bddd4&.jsrand=4948480&acrumb=4IGysPic.Eo&mcrumb=jjEJt2OdJjU&enc=auto&cmd=msg.flag" id="flag0" title="Flag this message"> <span class="offscreen">Flag this message</span></a></div><div><h1 id="message_view_subject">[ No Subject ]</h1><div class="date" id="message_view_date"><nobr>Wednesday, January 6, 2010 12:58 PM</nobr></div></div></div><div class="vcard"> <div class="row"> <div class="label">From: </div><div class="details"><a class="pim" href="http://help.yahoo.com/l/us/yahoo/mail/classic/context/context-07.html" id="domainkeys" target="_blank" title="This sender is DomainKeys verified"> <span class="offscreen">This sender is DomainKeys verified</span></a><div class="abook"><span class="email">"Gopa.India" <gopakumaradd@gmail.com></gopakumaradd@gmail.com></span></div><a class="pim addtoab" href="http://us.lrd.yahoo.com/_ylc=X3oDMTBsdTZpcnZpBF9TAzM5ODMwMTAyNwRhYwNhZGRBQg--/SIG=1uid7369i/**http%3A//address.mail.yahoo.com/yab%3Fv=YM%26A=m%26simp=1%26e=gopakumaradd%2540gmail.com%26fn=Gopa.India%26.done=http%253A%252F%252Fus.mc1108.mail.yahoo.com%252Fmc%252FshowMessage%253FsMid%253D5%2526filterBy%253D%2526.rand%253D1458030421%2526midIndex%253D5%2526mid%253D1_3765_AOgNw0MAAIONS0SI%25252FAcDTEdFsAg%2526m%253D1_380_AOINw0MAAJY2S03yKQX7JHY2nao%25252C1_914_AOINw0MAARUQS03VQwjARGsputc%25252C1_1486_AOcNw0MAASOjS03SgQssm28rszg%25252C1_2740_AOQNw0MAABSNS0yj8wR8d3F2VaA%25252C1_3288_AOwNw0MAAC1AS0mA9QjBPDTPK3Q%25252C1_3765_AOgNw0MAAIONS0SI%25252FAcDTEdFsAg%25252C1_4212_AOwNw0MAAHk9SzR7xg4x%25252B1VqZyc%25252C1_4766_AOkNw0MAAAhuSzRnEwrluycriFw%25252C1_5326_AO0Nw0MAAYFQSy%25252FHcQCi3E0%25252F%25252BFc%25252C1_5899_AOoNw0MAAUi%25252FSyjK7gwxQRhUKXY%25252C1_6472_AO4Nw0MAAMm3SjX0Zw8HfBNlqQ0%25252C%2526sort%253Ddate%2526order%253Ddown%2526startMid%253D0%2526hash%253Dbc2f385352863c9538c05e48284bddd4%2526.jsrand%253D4948480%2526acrumb%253D4IGysPic.Eo%2526enc%253Dauto" id="message_view_ab" title="Add sender to Contacts"> <span class="offscreen">Add sender to Contacts</span></a> </div></div><div class="row"> <div class="label">To: </div><div class="details">"Acharyaji Vrindavan" <saradchandraacharya@ymail.com></saradchandraacharya@ymail.com></div></div></div></div>Radhe Radhe!<br />
dear Acharyaji, im writing to u to ask for some advices. U remember i was with <span class="yshortcuts" id="lw_1263537370_0" style="border-bottom: 1px dashed rgb(0, 102, 204); cursor: pointer;">malaria</span> last year? i think i need to improve my inmunological system because it get weak after that. can u suggest me the <span class="yshortcuts" id="lw_1263537370_1" style="border-bottom: 1px dashed rgb(0, 102, 204); cursor: pointer;">ayurvedic treatment</span> i should follow for this and for my leber improvement?<br />
I hope u are happy in <span class="yshortcuts" id="lw_1263537370_2">orissa</span> and that ur proyect is going as good as u like.<br />
:)<br />
gopaSEVIKA ASRAMhttp://www.blogger.com/profile/09757876524180224516noreply@blogger.com0